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i 
 
 
The regulation of the Western beauty care products is currently inadequate and a huge concern to 
consumers throughout the world, as most of the products manufactured by personal care industry 
are made of synthetic additives, while the traditional skin-care products are safe products made 
from natural elements. Usage of traditional medicinal plants is perceived as a superior alternative 
to achieve improvement of the gradually deteriorating standard of manufacturing beauty care 
products. Therefore, the present study assesses the suitability of several South African plant 
species conventionally used in traditional medicine for skin hyperpigmentation treatment. Ten 
plant species, viz. Cassine peragua, Cassipourea gummiflua, Clivia miniata, Cryptocarya 
myrtifolia, Gunnera perpensa, Kigelia africana, Protorhus longifolia, Rapanea melanophloeos, 
Rhynchosia villosa, and Senecio serratuloides were obtained after interviewing fifteen traditional 
healers within the Eastern Cape Province. 
 
The methanolic extracts of the ten suggested plants were subjected to a preliminary bio-
evaluation against the tyrosinase enzyme. The results showed that Rhynchosia villosa root was 
the most active extract and hence, the R. villosa extract was subjected to further chromatography 
and studied. Five known flavonoids were isolated for the first time from R. villosa. The isolated 
constituents include genistein (C1), cajanin (C2), 2′-hydoxygenistein (C3), catechin (C4), and 
gallocatechin (C5). The tyrosinase inhibitory activity of the isolated compounds showed the 
highest activity for C1 (31.45 µM), followed by C4 (36.86 µM), C2 (38.97 µM), C5 (60.40 
µM), and lastly C3 (69.49 µM). 
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To the best of our knowledge, and according to an extensive search of the Sci-Finder database, 
the dissertation is the first scientific report to be carried out on the phytochemical and tyrosinase 
inhibition of R. villosa plant species. The R. villosa showed a high tyrosinase inhibitory activity, 
which makes it a likely candidate as a tyrosinase inhibitor that may be used as depigmenting 
agent for the treatment, or prevention, of pigmentation disorders in relation to 
hyperpigmentation. Furthermore, the results obtained also justify the traditional uses of the plant 
for skin depigmentation. 
Keywords: tyrosinase enzyme, hyperpigmentation, traditional medicine, Rhynchosia villosa. 
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The Rhynchosia villosa methanolic extract afforded the following five compounds:    
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WHY NATURAL PRODUCTS STUDY IN COSMETICS? 
"The perception is that natural ingredients are more pure and kinder to skin than something 
made in the lab, but nothing could be farther from the truth" — Dr. Joel Schlessinger 
1.1 THE PROBLEM 
 
Epidemiological data shows that about 35 % of women in South Africa use skin whitening 
products, which consist of synthetic chemicals, to bleach their skin (United Nation 
Environmental Programme, 2008). The inadequate regulation of beauty care products is a global 
issue. This is attested to by the dialectical claims emanating from various environment extremist 
groups, such as the Campaign for Safe Cosmetics and the Environmental Working Group, who 
proclaim that many of the cosmetics used by consumers worldwide are poisonous (Gattuso, 
2011). According to their research, it has been found that a number of cosmetics consist of 
paraben compounds; such compounds are linked to breast cancer and hormone dysfunction 
(Gray, 2010; Environmental Working Group, 2016). The most common dermatological disorders 
in S. Africa are associated with hyperpigmentation; this is due to the fact that 91 % of the S. 
African population has a dark complexion. Dermatological studies conducted in Durban amongst 
900 women with dark complexions showed that 67 % of the women who frequently use skin 
whitening products have genuine hyperpigmentation disorders (Webmaster, 2014). 
1.2 SOUTH AFRICAN FLORA USE IN TRADITIONAL MEDICINE 
 
It is clear that more work needs to be done in enhancing the standard of cosmetics. Hence, the 
use of traditional medicinal plants which consist of natural products is regarded as an efficient 
way to ameliorate the standard of manufacturing beauty care products. In the context of the 
CHAPTER ONE 
INTRODUCTION 
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dissertation, the phrase „natural products‟, refers to substances or compounds that are produced 
by nature and they are directly extracted from plants (Dorland‟s Illustrated Medicinal Dictionary, 
2000). On that note, the abundance of plant species in S. Africa is exceptional. S. Africa is one of 
the most plant fecund countries, consisting of approximately 23 420 plant species of about 368 
families, with more than 50 % of such flora found nowhere else in the world (Cowling and 
Hilton-Taylor, 1994; Willis, 2006).  
Nonetheless, apart from the profusion of plant species in S. Africa, knowledge regarding the 
phytochemistry and efficacy of such plant species remains insufficient. Thus, out of the 
enormous number of plant species found within the country, only 50 plant species are presently 
traded to any substantial level (Welford and Le Breton, 2008). This therefore necessitates more, 
efficient research, which will lead to innovative use of the S. African plants. The approach of 
using plant species in the discovery of therapeutics remains an ultimate reservoir for the effective 
usage of plants (Hostettmann, 1998).  
Although the exploitation of plant species is quite meager when it comes to commercialization in 
the African continent as a whole, it is certain that the traditional medicinal practice and use of 
remedies made from indigenous plants play a significant role in the primary health care of 
millions of sub-Saharan African natives. This claim is attested to by the International 
Development Research Centre (IDRC), and according to the IDRC survey, about 85 % of 
Africans occupying the sub-Saharan African regions depend on traditional healers and their 
remedies for primary health care (Stanley, 2004). This claim is also supported by the large 
number of traditional medicinal practitioners within each sub-Saharan African country. In S. 
Africa alone, there are about 200 000 traditional healers (Willis, 2006).  
 
 
 
 
C1C2 
 
 
 
C3 
 
 
                            C4                                   C5 
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Furthermore, the use of traditional medicinal plants as a primary health care by a variety of 
culturally diverse African populations has existed for thousands of years, long before the 
introduction of the Western medicine (Veilleux and King, 1996). Traditional medicinal remedies 
are used to treat a variety of ailments and infections, which include tuberculosis, nervous 
complaints, depression, headache, fever, rebalancing the digestion system, and skin disorders, to 
mention but a few. Therefore, the current study focuses on the treatment of skin disorders, 
particularly the treatment of skin hyperpigmentation by the usage of medicinal plants. 
1.3 NATURAL COSMETICS 
 
The usage of traditional medicinal plants in curing dermatological disorders is perceived as the 
most efficient approach, to such an extent that beauty care manufacturers predominantly adopt 
this method to produce „friendly‟ skin-care products (Draelos, 2008). This approach of using 
natural products in the manufacturing of cosmeceuticals is encouraged by the fact that, unlike 
synthetic drugs which are harmful to the skin, they result in improvement of the skin appearance 
through the delivery of nutrients which are necessary for a healthy skin (Rebeiro et al., 2015). 
Scientific findings show that traditional medicinal plants were amongst the first beauty care 
products, and, interestingly, the use of natural products in manufacturing cosmeceuticals is still 
perceived as an efficient method, but with substantial advancements. Thus, with new formulation 
techniques, control of raw materials and greater standardization are achieved, the aforementioned 
advances have led to innovative cosmeceuticals (Kirk-Othmer, 2013).  
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1.4 AIM OF THE STUDY 
 
The ultimate aim of the current study is to evaluate several plants traditionally used for the 
treatment of skin disorders, as tyrosinase inhibitors, and then select the most active extract for 
further investigation.  
1.5 OBJECTIVES OF THE STUDY 
 
The purpose of the research project is to: 
 Collect various plant species which are conventionally used for skin hyperpigmentation 
from their natural habitats, identify and document them.  
 
 Assess the extracts of Cassine peragua (bark), Cassipourea gummiflua (bark), Clivia 
miniata (root rhizome), Cryptocarya myrtifolia (stem bark), Gunnera perpensa 
(rhizome), Kigelia africana (fruit), Protorhus longifolia (bark), Rapanea melanophloeos 
(bark), Rhynchosia villosa (root and leaves), and Senecio serratuloides (leaves) against 
tyrosinase activity. 
 
 Use various chromatographic methods to separate bioactive compounds and to use 
bioassays to detect activity from the most active extract against the tyrosinase enzyme. 
 
 Thereafter, the active compounds would be characterized, identified, and evaluated 
against the tyrosinase enzyme. 
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2.1 GENERAL REVIEW 
 
2.1.1 SOUTH AFRICAN FLORA 
 
The world comprises of approximately 260 000 plant species (Miller and Spoolman, 2008). As 
mentioned previously, S. Africa is a country that encompasses a large number of plant species; 
coming sixth after Brazil (56 215), Columbia (51 220), China (32 200), Indonesia (29 375) and 
Mexico (26 071), with 23 420 plant species (Butler, 2016). S. Africa is the only country in the 
world with an entire plant kingdom within its boundaries, and around 10 % of the world‟s 
flowering plant species (angiosperms) are found in S. Africa (Fry, 2010; Germishuizen and 
Meyer, 2003). The world is divided into six floral kingdoms, namely, Boreal Kingdom (20 
million km
2
), Antarctic Kingdom, Neotropical Kingdom, Australian Kingdom, Paletropical 
Kingdom, and the smallest, but ironically the most diverse of them all, is the Cape Floral 
Kingdom of the Western Cape Province of S. Africa, with only a 90 000 km
2
 surface area 
(Charters and Madre, 2015). 
 
The Cape floristic region (CFR) is the most fertile region on Earth, as it consists of the highest 
density of plant species globally with 31.9 % of the species being endemic (Takhtajan, 1986). 
This kingdom comprises roughly 8 700 plant species, with approximately 6 000 (69 %) plant 
species found nowhere else in the world (Goldblatt, 1978; Bond and Goldblatt, 1984). The CFR 
ranges from Cape Point (W. Cape Province) to Grahamstown (Eastern Cape Province) and 
minimally into the Northern Cape Province (Figure 2.2). Although the CFR only represents less 
than 0.5 % of the African continent‟s land surface area (Figure 2.1), it is home to nearly 20 % of 
CHAPTER TWO 
LITERATURE REVIEW 
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the continent‟s flora, making the CFR rank number seven in the biodiversity „hotspots‟ of the 
world (Goldblatt and Manning, 2000). 
 
Retrieved from SlidePlayer website: http://slideplayer.com/slide/8466137/ 
Figure 2.1: Floristic regions throughout the world. 
 
The CFR is one of S. Africa‟s eight World Heritage sites and is made up of eight protected areas 
(Figure 2.2) that are considered to be the most important examples of the CFR, namely, Cape 
Peninsula National Park (Table Mountain), Boland Mountain Complex, Groot Winterhoek 
Wilderness Area, Cederberg Wilderness Area, De Hoop Nature Reserve, Boosmansbos 
Wilderness Area, Swartberg Mountains, and Baviaanskloof Wilderness Area, such areas spans 
from the Cape Peninsula to the E. Cape Province (Anon, 1999). 
Map 1 
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Retrieved from UNESCO website: http://whc.unesco.org/uploads/nominations/1007rev.pdf 
Figure 2.2: Cape floristic region. 
 
Moreover, the primary vegetation type of the W. Cape is „fynbos‟ (word derived from Afrikaans 
meaning „fine bush‟), and this distinctive vegetation of sclerophyllous shrubland constitute about 
80 % of all the vegetation of the Cape Floral Kingdom, while 20 % is shared amongst other 
vegetation such as Thicket biomes, Nama Karoo and Succulent Karoo (Anon, 1999). There are 
five main vegetation types of fynbos; mountain fynbos being the largest, followed by grassy 
fynbos, sand-plain fynbos, laterite (coastal) fynbos, and limestone fynbos, and their distribution 
within the CFR is depicted in Figure 2.3 (Low and Rebelo, 1996). 
 
 
Map 2 
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*Source: Low and Rebelo, 1996 
 
 
Retrieved from Calflora.net website: http://www.calflora.net/southafrica/capeflora.html 
Figure 2.3: Main fynbos vegetation types.  
 
 
 
 
*Map 3: Mountain fynbos distribution 
*Map 4: Grassy fynbos distribution 
*Map 5: Sand-plain fynbos distribution 
*Map 6: Laterite  fynbos distribution 
*Map 7: Limestone fynbos distribution 
 
 
 
 
Map 3 
Map 4 
Map 5 
Map 6 
Map 7 
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Moreover, the fynbos biome is mainly made up of fine-leaved shrubs such as heaths (Ericaceae), 
larger-leaved showy flowered (Proteaceae), bunches of reed-like (Restionaceae), and fan-like 
(Iridaceae) plants (Bond and Goldblatt, 1984). The plant taxa recorded for S. Africa varies over 
time, due to new discoveries and taxonomic research. For instance, 268 new species of S. 
African plants have been described between 1994 and 2004 (Willis, 2006), hence the information 
in Table 2.1 below may have changed slightly as it was documented in 1984. 
Table 2.1: The largest families and genera in the Cape Flora Kingdom 
 
 Family  Total species  Endemic species  Largest genus  Species 
 Daisy: Asteraceae 986 608 Senecio 133 
 Heath: Ericaceae 722 700 Erica 550 
 Vygle: Mesembryanthemaceae 660 507 Ruschia 138 
 Pea: Fabacea 644 525 Aspalathus 245 
 Iris: Iridaceae 612 485 Gladiolus 88 
 Protea: Proteaceae 320 306 Leucadendron 80 
 Cape reed: Restionaceae 310 290 Restio 85 
 Figwort: Scrophulariaceae 310 160 Selago 59 
 Buchu: Rutaceae 259 242 Agathosma 130 
 Bellflower: Campanulaceae 222 157 Lobelia 42 
 Orchid: Orchidaceae 206 124 Disa 52 
 Sedges: Cyperaceae 203 124 Ficinia 57 
 Milkwort: Polygalaceae 139 117 Muraltia 106 
 Jujube: Rhamnaceae 136 122 Phylica 133 
 Storkbill: Geraniaceae 133 67 Pelargonium 125 
 Sorrel: Oxalidaceae 129 90 Oxalis 129 
 Rose: Rosaceae 114 97 Cliffortia 106 
*Source: Bond and Goldblatt (1984) 
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2.1.2 NATURAL PRODUCTS AND THEIR USE IN COSMETICS 
 
As stated above, although there is a surplus of plant species in S. Africa, these plants have not 
been effectively used. It has been identified that all plant species produce natural products. These 
plant-derived substances, also known as „natural ingredients‟ or „secondary metabolites‟, can be 
found in different parts of the plant, i.e., the roots, flowers, stems, barks, fruits, leaves and seeds 
(Chugh et al., 2012). Each and every plant species has a distinctive mechanism for 
biosynthesizing secondary metabolites, referred to as secondary metabolism (Scheme 2.1) and 
such mechanism is responsible for the uniqueness of a plant species (Maplestone et al., 1992). It 
is very important to note that natural products or secondary metabolites are unnecessary for the 
growth of the plant species, although they contribute to its colour, aroma and flavour (Fraenkel, 
1959; Saxena et al., 2013).  They come into existence in plant species due to the environmental 
conditions under which the plant germinates (Colegate and Molyneux, 2008). Natural products 
are also produced to protect the plant species against predators, pollution, stress, drought, 
ultraviolet (UV) exposure and pathogenic attacks (Schafer and Wink, 2009). 
In terms of the chemistry, the secondary metabolites are classified based on their chemical 
structures, composition and their solubility in various solvents or the pathway in which they are 
synthesized (Kabera et al., 2014). The various groups of secondary metabolites include alkaloids, 
steroids, terpenoids, phenols, flavonoids, tannins etc. and they are differentiated by the functional 
groups present (Krishnaiah et al., 2007). Such compounds are a subdivision of three chemically 
distinct groups, namely, nitrogen-containing secondary products, phenolic compounds and 
terpenes (Van Wyk and Wink, 2004).  
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Retrieved from NPTEL website: http://nptel.ac.in/courses/102103016/module4/lec31/2.html 
Scheme 2.1: Major pathways of secondary metabolites biosynthesized from primary metabolites 
(Secondary metabolism). 
 
It has been observed that each plant species produces a characteristic mix of these bioactive 
compounds, which are regarded to be high value products compared to their precursors, the 
primary metabolites (Veberič, 2010). Secondary metabolites are considered to be fine chemicals, 
and are extensively used as pharmaceuticals, flavourants, pesticides, cosmetics, etc. (Balandrin et 
al., 1985). The focal point of the present study is based on the latter, i.e., the use of natural 
products in cosmetics. The use of natural products in cosmetics has existed for centuries and has 
evolved drastically in recent years. As mentioned previously, natural products are perceived as 
components that have less adverse effects compared to synthetic drugs; thus, they are observed 
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as natural and free from all the harmful synthetic chemicals, with anti-tyrosinase, antioxidant and 
antimicrobial activities (George, 2011; Rebeiro et al., 2015).   
On the same note, being beautiful and feeling young are qualities that give the sense of pleasure 
and are, perhaps, the desire of every human being throughout the world. Hence the prevalent use 
of cosmetics (Kapoor, 2005). A huge problem is that many cosmetics consist of synthetic 
additives which are harmful or poisonous, leading to a rising number of consumers being 
concerned about marketed cosmetics. Thus the demand for cosmetics with traceable and more 
natural ingredients, free from harmful chemicals and with an emphasis on the rejuvenative 
properties of botanicals is instigated (Ferrer et al., 2012). 
It is crucial to define the term „cosmetics‟ in order to avoid misperceptions. According to the 
European Parliament and the Council of the European Union (2009: 64), „cosmetic‟ refers to: 
Any substance or mixture intended to be placed in contact with the external parts of the 
human body (epidermis, hair system, nails, lips and external genital organs) or with the 
teeth and the mucous membranes of the oral cavity with a view to exclusively, or mainly, 
to cleaning them, perfuming them, changing their appearance, protecting them, keeping 
them in good condition or correcting body odours.  
Also, a misconception between the term „cosmetics‟ and „cosmeceuticals‟ is frequently 
discerned. The term „cosmeceuticals,‟ particularly refers to cosmetics that are known to have 
healing properties. Thus, it serves as a combination between drug effect and cosmetic effect; 
cosmeceuticals are intended to improve both the health and beauty of the skin by external 
application (Elsner and Maibach, 2000). The research is based on examining the tyrosinase 
inhibitory effect of natural products from medicinal plants which are traditionally used as 
cosmeceuticals. 
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2.1.3 TYROSINASE EFFECT 
 
Tyrosinase, also known as polyphenol oxidase (PPO), is defined in The American Heritage 
Dictionary of an English Language (2016) as “any of a family of copper-containing enzymes 
found in animal and plant tissues, fungi and bacteria, that catalyze the oxidation of phenolic 
compounds and are responsible for the production of the pigment melanin from tyrosine and for 
the browning of fruits, vegetables, and mushrooms when cut and exposed to air”. The interest of 
the current research is mainly centered on inhibition of the tyrosinase enzyme, to avoid extra 
production of the human pigment melanin. Melanin is the pigment accountable for the colour of 
the eyes, hair and skin; its occurrence in human skin, takes place in a cell called melanocyte via a 
process known as melanogenesis (Sturm et al., 1998). Melanogenesis is in control of the 
biological reactions that defend the skin from free radical attacks which lead to cellular injury of 
the skin (Narayanaswamy et al., 2011). 
Scheme 2.2 portrays the biosynthesis of melanin (melanogenesis). In the process, tyrosinase 
increases the rate of the transformation reaction of L-tyrosine to L-dopa by hydroxylation and it 
also leads to the formation of dopaquinone from L-dopa by oxidation (Mason, 1955). A fast 
transformation of dopaquinone to dopachrome occurs via series of non-enzymatic reactions 
(Seiji, 1967). Tyrosinase appears once again in the process, catalyzing the rate of transformation 
from dopachrome to the formation of melanin. Dopachrome is regarded as a possible control 
point of melanin biosynthesis (Körner and Pawelek, 1980). However, not all substances that can 
inhibit the formation of dopachrome are tyrosinase inhibitors, e.g., thymol (Satooka and Kubo, 
2011). Melanocyte cells are capable of producing two types of melanin pigments viz.„eumelanin‟ 
(black or brown) and „pheomelanin‟ (red or yellow) as depicted in Scheme 2.3 (Commo et al., 
2004). 
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Retrieved from Pepperdine Biochemistry 
website:http://biochem.pepperdine.edu/dokuwiki/doku.php?id=chem330:fall2013:lab_3_--
_ph_dependence_of_enzymatic_activity_harry_potter_edition 
Scheme 2.2: Melanin biosynthesis (Melanogenesis process). 
 
Retrieved from BIL 250 website: http://www.bio.miami.edu/dana/250/250SS15_6.html 
Scheme 2.3: Production of different pigments by melanocytes. 
 
http://etd.uwc.ac.za/
     
 15  
 
Since melanogenesis is a series of biological reactions which proceeds through a free radical 
mechanism, it could be disrupted by the selective use of antioxidants which are effective enough 
to alter these reactions (Momtaz et al., 2008). The unavoidable production of free radicals, such 
as different reactive oxygen species (ROS) of aerobic metabolism, leads to cellular injury of the 
skin (Devasagayam et al., 2004). These harmful oxidants are mainly due to environmental 
pollutants and UV radiation from sunlight and together with other free radicals damage the skin, 
instigating skin disorders (Silva et al., 2010). ROS increase the melanin biosynthesis, which is 
detrimental to deoxyribonucleic acid (DNA) and they are likely to cause proliferation of 
melanocytes (Yasui and Sakurai, 2003). 
 
As stated above, the enzymatic effects of tyrosinase are also found during browning of food 
when stored or processed in air.  Such effects lead to a loss of nutritional quality, decrease in 
digestibility and formation of anti-nutritional and toxic compounds in the food (Friedman, 1996). 
Hence, tyrosinase inhibitors are also needed to inhibit browning reactions and preventing adverse 
effects of browning during food storage, processing and consumption (Rao et al., 2013). 
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2.1.4 SKIN DISEASE; HYPERPIGMENTATION 
 
The largest and outermost organ in the human body is the skin. It has a surface area of 
approximately 1.8 m
2
 and accounts for about 16 % of the body mass in the average adult 
(Thomas, 1993; D‟Orazio et al., 2013). This organ is made up of three layers (Figure 2.4), viz. 
the epidermis (which acts as a barrier to external influences and water loss from the inside), 
dermis (contains blood vessels to supply oxygen and nutrients), and subcutaneous tissue also 
known as hypodermis, which consists of connective tissue and fat (Weller et al., 2008). 
Generally, the skin protects the body from the external environment, regulating temperature, 
aiding in fluid balance, prohibiting dangerous microbes and chemicals from the body and 
defending the body from the sunlight (Rebeiro et al., 2015). Thus, the skin is the most vulnerable 
organ to invasion by bacteria, viruses, and other toxic elements (Narayanaswamy et al., 2011).  
 
Retrieved from National Cancer Institute website:http://www.cancer.gov/types/skin/hp/skin-genetics-pdq 
Figure 2.4: Three-dimensional diagram of the skin. 
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It is known that 34 % of all occupational diseases are skin disorders (Spiewak, 2000). Skin 
disorders have a great variation, particularly when it comes to symptoms and severity, thus, they 
can be classified as genetic or circumstantial, permanent or temporary, lethal or harmless, painful 
or painless (Brind‟Amour, 2016). UV radiation from the sun is seen as the major cause of skin 
diseases. Penetration of UV radiation leads to variations in the composition of the skin, including 
accumulation of the elastic fibers, collagen reduction and degeneration, and the deposition of 
glycosaminoglycan (Braverman and Fonferko, 1982; Olikarnin and Kallionen, 1989; Smith et 
al., 1962). It also leads to various skin disorders (Scheme 2.4) such as, skin cancer, age spots, 
photosensitivity, moles, polymorphous light eruption (PMLE), solar elastosis (wrinkles), etc. 
(Kennedy, 2015). 
 
Retrieved from Healthy Fellow website: http://www.healthyfellow.com/220/skin-aging-and-ellagic-acid/ 
Scheme 2.4: Summary of the effects of UV irradiation on skin. 
 
C 
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Skin darkening (i.e., hyperpigmentation) is a result of extra production of melanin, which is 
mainly associated with UV radiation. However, UV radiation is not the only cause of 
hyperpigmentation, other causes include genetic disposition, aging, hormonal influences, air 
pollution and skin injuries or inflammatory skin conditions (Drakaki et al., 2014). 
Hyperpigmentation is also a side effect of certain hormone treatments, chemotherapy drugs, 
antibiotics, anti-seizure drugs, and other medications (Butler and Elston, 2016).  
Hyperpigmentation disorders are differentiated based on the multiple mechanisms that produce 
various types of discolourations, spots, or marks. The different types of hyperpigmentation 
include ephelide (freckles), sun spots (age spots), stretch marks, moles, melanoma, post-
inflammatory hyperpigmentation (PIH), melasma (chloasma), seborrheic keratoses, acanthosis 
nigricans, diabetic dermopathy, tinea versicolor (pityriasis versicolor), etc. (Just About Skin, 
2014; Stulberg et al., 2003). However, not all of the above-mentioned forms of 
hyperpigmentation are explained in the scope of the dissertation, thus, only the common forms of 
hyperpigmentation, particularly in S. Africa is discussed. 
Melasma is one of the most common types of hyperpigmentation. It is also known as chloasma 
or „pregnancy mask‟. Although the latter name and the fact that an estimated 70 % of women 
who get affected by this hyperpigmentation during their pregnancy might suggest that melasma 
is only for pregnant women, this is simply not true, as studies revealed that 10 % of men have 
such skin discolouration too (Moin et al., 2006; Vazquez et al., 1988). Of course, such 
hyperpigmentation is common to pregnant women, particularly those with a darker complexion, 
but, it also affects adolescents and older women as a result of side effects of certain medications 
(Jadotteand Schwartz, 2010). Melasma appears as dark patches or hyperpigmented macules on 
the face, neck and rarely the upper limbs (Bagherani et al., 2015). It is somewhat idiopathic, 
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especially to men, thus, its pathogenesis is unclear, but it is anticipated to be due to UV radiation, 
anti-seizure medications, hormonal variations of pregnancy and thyroid disease (Cayce et al., 
2004). 
Another common type of hyperpigmentation is that of post-inflammatory hyperpigmentation 
(PIH). PIH is a skin condition that results from preceding cutaneous disorders, such as trauma 
(e.g., burns), inflammatory diseases (e.g., lichen planus, lupus erythematosus, atopic dermatitis), 
infections, allergic reactions, mechanical injuries, reactions to medications, and phototoxic 
eruptions (Schwartz and Elston, 2015). Lentigo is a common hyperpigmentation disorder; this 
hyperpigmentation is a circumscribed brown spot resulting from an increased number of 
melanocytes at the dermoepidermal junction (Ortonne, 2003). Lentigines can occur in any area 
of the skin, and they are classified in accordance with aetiological factors, thus, some lentigines 
are associated with too much exposure to UV radiation (e.g., lentigo simplex, solar lentigo, 
photochemotherapy (PUVA) lentigo, reticular/ink-spot lentigo, and sunbeds lentigo), some are 
not associated with overexposure to UV radiation (e.g., genital lentiginosis, labial lentigo, and 
oral lentiginosis), and other lentigines are characteristic feature of multisystem syndromes (Carli 
and Salvini, 2009). 
Care is needed in differentiating these spots and moles, as they are subtle to those which are 
symptoms of Melanoma. Melanoma is the most dangerous form of skin cancer, it develops in the 
melanocyte, when unrepaired DNA damage due to UV radiation causes mutations (genetic 
defects), making the skin cells multiply rapidly, forming malignant tumours (Skin Cancer 
Foundation, 2016). Melanoma tumours can grow anywhere in the skin, yet they are likely to 
begin in the trunks (chest and back) in men and on the legs in women. They are brown or black 
in colour, however some can appear pink, tan, or white (American Cancer Society, 2016). 
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Melanoma is regarded as the most harmful skin cancer type since it is likely to spread to other 
parts of the body if not caught early and due to its reluctance to chemotherapy (Marieb and 
Hoehn, 2013). 
Furthermore, pigmentation disorders in relation to hyperpigmentation are closely associated with 
Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It has 
been shown that HIV infected people are more likely to have dermatological disorders; the 
prevalence is revealed to approach 100 % (Koehler et al., 1992). The most common type of 
hyperpigmentation or PIH disorder affecting approximately 75 % of the people with HIV in S. 
Africa is that of morbilliform eruption (Jordaan, 2008). Other hyperpigmentation disorder 
associated with HIV-affected people is that of HIV-associated oral mucosal melanin 
hyperpigmentation (HIV-OMH). In S. Africa, HIV-OMH was found to be 18.5 %; relatively 
high when compared to other sub-Saharan African countries, e.g., Tanzania 4.7 % and Kenya 6 
% (Chandran et al., 2016; Chandran et al., 2014). Moreover, some hyperpigmentation or PIH 
associated with HIV include Kaposi's sarcoma, seborrheic dermatitis, psoriasis, cutaneous 
vasculitis, thrombocytopenic purpura, pemphigoid, autoimmune blistering, etc. (Knott, 2015). 
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2.2 REVIEW OF RHYNCHOSIA VILLOSA 
 
2.2.1 FABACEAE 
 
Fabaceae is the predominant family of the plant order Fabales, and it constitutes nearly 95 % of 
this order, while 5 % is shared among Polygalaceae, Surianaceae, and Quillajaceae families 
(Turner, 2016). It is also one of the largest families of flowering plants (angiosperms), following 
Asteraceae and Orchidaceae, respectively, with about 19 400 recognized plant species of 
approximately 751 genera; such plant species amount to almost 7 % of angiosperms (Judd et al., 
2002; Christenhusz and Byng, 2016). Fabaceae is also scientifically known as Leguminosae or 
Papilionaceae, but, often called legume, pea or bean family (International Association for Plant 
Taxonomy, 2012). This family has three distinct subfamilies, namely, Faboideae, 
Caesalpinioideae, and Mimosoideae which have been recognized to be the only phylogenetic 
from this family 55–50 MYA; these subfamilies used to be treated at the family level (Herendeen 
et al., 1992). 
2.2.2 RHYNCHOSIA; RHYNCHOSIA VILLOSA  
 
Rhynchosia is one of the ten genera of the subtribe Cajaninae of tribe Phaseoleae; Phaseoleae is 
amongst the 28 tribes of subfamily Faboideae (Moteetee et al., 2012). Rhynchosia genus has 
approximately 230 plant species which are prevalent the most in Africa, with approximately 60 
of such species occurring in S. Africa (Schrine, 2005; Germishuizen 2006). They are also found 
in other continents, particularly in climates characterized by warm temperatures, such as tropical 
Asia, northern Australia, and also in tropical and subtropical America (Schrine, 2005). The plant 
species of Rhynchosia which occur in S. Africa were separated based on morphological 
structures into five sections by Baker in 1923; such sections include Cyanospermum (Wight and 
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Arnott) Benth. (1 species), Arcyphyllum Torrey and Gray (2 species), Polytropia Presl. (2 
species), Chrysoscias E. Mey (4 species), and Eurhynchosia Baker (50 species) (Baker, 1923). 
 
Rhynchosia belongs to the Eurhynchosia section and is closely related to Eriosema, which also 
falls within the same section, and is also one of the Cajaninae genera. The two genera have 
similar pinnately compound leaves and axillary racemes (Doyle and Doyle, 1993; Lackey, 1981). 
Such close relation between the two genera is attested to by the similarity of the morphological 
structure of the plant species of interest, Rhynchosia villosa, to that of Eriosema cordatum. Both 
plant species develop a perennial underground organ, an erect rootstock. Also, both plant species 
have stems and leaves with observable pubescence, and flowers of the inflorescences are yellow 
in colour with red veins, but the size and shape of the leaves of these two species are different, as 
the leaves of R. villosa adopt a peltate shape, while those of E. cordatum assume an ovate shape 
(Stirton and Gordon-Gray, 1978; Amrisha, 2015). However, the lack of anatomical and 
developmental studies on these plant species makes it problematic to precisely differentiate these 
plant species, as it is sometimes unclear to tell where root gives place to stem (Stirton and 
Gordon-Gray, 1978).  
Moreover, the synonym of R. villosa, which is Eriosema villosum also substantiate the close 
relation between these two genera. Eriosoma villosum is not the only synonym of R. villosa; 
other known synonyms are Rhynchosia sigmoides and Sigmodostyles villosa. Nonetheless, R. 
villosa is endemic to S. Africa and widely distributed in KwaZulu-Natal (KZN), Mpumalanga 
Province, and E. Cape Province (Foden and Potter, 2005). This plant species is known as 
„Uphuzi lobala’ or „Uphuzi lentaba’ by the people of the Pondoland, its Xhosa name is derived 
from that of Gunnera perpensa, which is„Uphuzi lomlambo,‟ under the misapprehension that the 
two plants are phylogenetical and/or morphological related. 
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2.2.3 TRADITIONAL USES OF R. VILLOSA 
 
The similarity of R. villosa (E. villosum) and E. cordatum is not merely based on their 
morphological structures and names, but also on their pharmacological activities. Thus, the root 
of R. villosa is posited to be traditionally used and interchangeable with that of E. cordatum, and 
other two Eriosoma species, E. salignum and E. kraussianum by the people of KZN for male 
sexual disorders, which include erectile dysfunction and/or male potency, hence this, suggests 
that they consist of some aphrodisiac activity (Drewes et al., 2013). The above-mentioned plant 
species are collectively known by the people of KZN as „Ubangalala,‟ and they have been used 
by the S. African men or Zulu warriors for centuries to enhance their sexual energy and potency 
(Hutchings, 1996).  
 
Alternatively, the R. villosa root is utilized by the people of the Pondoland as the main 
constituent in the fusion or decoction that helps women with fertility problems. Therefore, this 
suggests that the plant species of interest has estrogenic properties, which is attributed to its use 
as the ovulatory stimulant. Moreover, the people of Lusikisiki mainly use R. villosa root in 
cosmetic preparations. It is used externally and internally to enhance the skin texture and tone, 
while it also aids in treating swollen parts of the body when washed with water that has soaked 
leaves of this plant. The pharmacological and ethnopharmacological uses of some Rhynchosia 
species are presented in Table 2.2. 
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Table 2.2: Pharmacological and ethnopharmacological uses of some Rhynchosia species 
 
Plant Source         Location          Pharmacological and                                               Reference(s) 
ethnopharmacological use(s) 
R. rothii                    India                  Tonic                                                           (Gauri and Sharma, 2011)
 
R. rufescens              India                  Abortion                                                                (Ajesh et al., 2012)      
R. beddomei              India                 Antioxidant, anti-inflammatory,            (Sridharamurthy et al., 2013) 
                                                            analgesic, diuretic activity,                            (Eswaraiah et al., 2013) 
                                                            and microbial activity                                   (Bakshu and Raju, 2001) 
R. scarabaeoides     India                    Antibacterial activity                                           (Challa et al., 2011) 
R. minima                 India, USA         Anthelmintic activity                                   (Mali and Mahale, 2008)
 
                                  and Sri Lanka 
R. volubilis                Japan                  Antiproliferative activity                                      (Kinjo et al., 2001) 
                                  and Korea           and used as cosmeceuticals                                   (Hong et al, 2016) 
 
R. hirta                      Kenya                 Malaria                                                           (Pascaline et al., 2011)
 
R. nulubilis                Korea                  Antioxidant,                              (Yim et al., 2007; Kim et al., 2009) 
                                                              and antinociceptive 
 
R. molubils                Korea                   Antioxidant                                                                      (Ha, 2006) 
                                                               and anti-tyrosinase activity 
 
R. precatoria             Mexico                Tuberculosis                                    (Coronado-Aceves et al., 2016)
 
R. caribaea                Namibia               Analgesics                                           (Dushimemaria et al., 2015)
 
 
R. capitata                 Pakistan               Gastric problems flatulence,                             (Wariss et al., 2014)
 
                                                                constipation, purgative, headache,             
                                                                nausea and vomiting 
 
R. reniformis              Pakistan                Antiglycation, platelet aggregation,               (Ahmad et al., 2011)
 
                                                                 antioxidant, cytotoxic and phytotoxic 
 
R. viscosa                   Tanzania               Inflammatory skin disorders                      (Crawford et al., 2010) 
                                                                 and insect bites 
 
R. recinosa                 Tanzania,              Peptic ulcers, and                                             (Haule et al., 2012) 
                                    and Zimbabwe     antileishmanial activity                               (Monzote et al., 2014)              
 
R. heterophylla            Zambia                 Fermentation of beverage                                 (Zulu et al., 1997) 
                                                                  and anti-inflammatory 
 
R. insignis                    Zimbabwe            Diarrhea                        (Chimponda and  Mukanganyama, 2010) 
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2.2.4 CHEMISTRY OF RHYNCHOSIA 
 
The chemistry of the Rhynchosia genus is not fully complete, since not many compounds have 
been identified from this genus. The insufficient information available about the chemistry and 
biology of this genus is due to the lack of work that has been done in examining its species in the 
many regions in which they occur, except in India. For instance, S. Africa has a huge number of 
Rhynchosia species (58), 57 % more than that of India (25), but information about their 
pharmacological activities is limited (Germishuizen, 2006; Baker, 1976; Sanjappa, 1992). As 
demonstrated by Tables 2.3.1–2.4.6, that show summary of the main compounds of Rhynchosia, 
intensive and novel work in this genus has been done in India by Adinarayana and core-workers. 
A comprehensive phylogenetic study of S. African Rhynchosia species was carried out by Baker 
in 1923. The literature available indicates that more pharmacological studies need to be done on 
the S. African Rhynchosia species. 
 
The class of Rhynchosia consists of herbs, commonly climbing or trailing, sometimes woody 
stock, rarely shrubs (Bisby, 1994). A large number of isolated constituents from the species of 
this genus have been obtained from leaves. The organic compounds which are most abundant in 
Rhynchosia are flavones, mainly C-glycosylflavones (Rao et al., 1991). Such constituents are 
distributed amongst edible fruits, cereals and leaves; they have important biological potential, 
such as anti-inflammatory, anti-diabetic, anti-spasmodic, anxiolytic, and hepatoprotective 
activities, hence their excellence use in human diet (Court and Williams, 2015). Also, a 
numerous number of compounds isolated from Rhynchosia are known as pro-antioxidant 
molecules. Such compounds include the flavones (1, 2, 6, 11, and 12), isoflavones (14 and 15), 
flavonols (29, 30, 32, 33, and 39), flavan-3-ol (40), flavanonols (42 and 43), phenolic acids 
and/or benzonoic acid derivatives (45 – 48), xanthone (53) and sterol (55) (Goufo and Trindade, 
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2014; Mathangi and Sudha, 2012; Banerjee et al., 2012; Battu et al., 2011; Rammohan et al., 
2015). Such compounds are found in food, suggesting that many species of Rhynchosia like 
other legumes also act as a potential source of edibles. 
 
The above-mentioned compounds substantiate the use of some of the Rhynchosia species as 
cosmeceuticals. As in the case of R. molubilis, which is reported to consist of antioxidants that 
lead to its ability to block UV radiation, automatically prevent oxidation and remove free-
radicals, it is also able to carry out skin-whitening action such as the inhibition of melanin 
formation (Ha, 2006). Another Rhynchosia species which has been found to be beneficial in 
depigmenting the skin and treating solar elastosis (wrinkles), is that of R. nolubilis, it has been 
revealed to be excellent in inhibiting melanin generation, while it can treat skin wrinkles through 
reducing the expression of collagenase MMP-1 and increasing the generation of collagen (Yim et 
al., 2009; Hong et al., 2016). On the other hand, Koreans also use R. volubilis as a major 
ingredient in local cosmetic formulations, as it is known to possess anti-inflammatory, 
antibacterial, anti-aging, skin whitening activities as well as prevention of wrinkles (Hong et al, 
2016; Lai et al., 2012).  
 
Generally, the extensive occurrence of the different classes of flavonoids (Table 2.3.1–2.3.6) in 
Rhynchosia supports the significance of this genus in cosmetic and pharmaceutical fields as anti-
inflammatory and antioxidant agents (Malinowska, 2013). Gallic acid (45) and the pyrogallol-
type tannins (41, 49, 51, 52, and 58) isolated from R. volubilis showed high antiproliferative 
activities against murine melanoma (B16F10) cells, hence this also promotes the cosmeceutical 
effects of the Rhynchosia species, i.e., R. volubilis, R. nolubilis and R. molubilis in particular 
(Kinjo et al., 2001). 
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Group 1: Flavonoids; 
 
Table 2.3.1: Flavones and flavone glycosides 
 
S/No. Chemical structure and name of  isolated 
compound 
Plant 
 source(s) 
Biological 
activity 
Reference(s) 
1 
 
 
 
Isovitexin 
R. suaveolens 
R. heynei 
R. capitate 
R. beddomei 
R. rufescens 
R. sericea 
R. rothii 
R. cana 
R.  jacobii 
R. bracteata  
R. minima 
 
Radical 
scavenging 
activity 
 
(Rammohan et al., 2015) 
 
(Adinarayana et al., 1985) 
 
(Rao and Gunasekar, 1987) 
 
(Adinarayana et al., 1980c) 
 
(Adinarayana et al., 1979) 
 
(Adinarayana and 
Ramachandraiah, 1986) 
 
(Seetharamamma et al., 1989) 
 
(Nia et al., 1992) 
 
(Besson et al., 1977) 
2 
 
 
 
Isoorientin 
R. suaveolens 
R. rufescens 
R. beddomei 
R. rothii 
R. capitate 
R. cana 
R.  jacobii 
 
Radical 
scavenging 
activity 
(Rammohan et al., 2015) 
 
(Adinarayana et al, 1985) 
 
(Adinarayana et al., 1979) 
 
(Adinarayana et al., 1980c) 
 
(Adinarayama and 
Ramachandraiah, 1986) 
 
(Adinarayana and Chetty, 
1985) 
 
(Rao and Gunasekar, 1987) 
 
(Seetharamamma et al.,1989) 
3 
 
Orientin 
R. cana 
R. jacobii 
R. heynei 
R. rufescens 
R. beddomei 
R. hirsuta 
R. rothii 
 (Adinarayana and 
Ramachandraiah, 1986) 
 
(Seetharamamma et al.,1989) 
 
(Adinarayana et al., 1979) 
 
(Adinarayana et al., 1980c) 
 
(Adinarayana et al., 1985) 
 
(Rao and Gunasekar, 1987) 
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4 
 
Vicenin-2 
R. rothii  
R. heynei 
R. hirsuta 
R. rufescens 
R. beddomei 
R. cana 
R.  jacobii 
R. minima 
 
Anti-
inflammatory 
(Rao and Gunasekar, 1987) 
 
(Adinarayana and 
Ramachandraiah, 1986) 
 
(Adinarayana et al., 1985) 
 
(Adinarayana et al., 1979) 
 
(Adinarayana et al., 1980c) 
 
(Seetharamamma et al., 1989) 
 
(Besson et al., 1977) 
5 
 
Lucenin-2 
R. cana 
R. beddomei 
R. rufescens 
R. rothii 
 
 (Adinarayana and 
Ramachandraiah, 1986) 
 
(Adinarayana et al., 1980c) 
 
(Adinarayana et al., 1980b) 
 
(Adinarayana et al., 1979) 
 
(Adinarayana et al., 1985) 
 
(Rao and Gunasekar, 1987) 
6 
 
Vitexin 
R. cana 
R. capitate 
R. heynei 
R. rufescens 
R. beddomei 
 (Adinarayana and 
Ramachandraiah, 1986) 
 
(Adinarayana et al., 1985) 
 
(Adinarayana et al., 1979) 
 
(Adinarayana et al., 1980c) 
7 
 
Vicenin-1 
 
R. jacobii 
 
  
(Seetharamamma et al.,1989) 
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8 
Vicenin-3 
 
R. minima 
  
(Besson et al., 1977) 
9 
 
Schaftoside 
 
R. minima 
  
(Besson et al., 1977) 
10 
 
3′,4′-di-O-methylluteolin-7-O-glucuronide 
 
R. beddomei 
 
  
(Adinarayana et al., 1980c) 
 
(Adinarayana et al., 1985) 
 
11 
 
Luteolin 
 
R. suaveolens 
 
  
(Adinarayana et al., 1985) 
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12 
 
Apigenin 
 
R. beddomei 
 
  
(Adinarayana et al., 1985) 
Table 2.3.2: Isoflavones 
 
S/No. Chemical structure and name  of  isolated 
compound 
Plant source(s) Biological 
activity 
Reference(s) 
13 
 
 
Cajanin 
 
R. edulis 
R. densiflora   
R. carabaea  
R. hirsuta 
 
  
(Ogungbe et al., 2011) 
 
(Ingham, 1990)
 
14 
 
Genistein 
 
R. densiflora  
R. carabaea    
R. hirsuta 
  
(Ingham, 1990) 
15 
 
 
2′-hydoxygenistein 
 
R. densiflora 
R. carabaea 
R. hirsuta 
 
 
 
 
(Ingham, 1990) 
16 
 
 
Ulexin B 
 
R. edulis 
 
 
 
 
(Ogungbe et al., 2011)
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17 
 
Scandenal 
 
R. edulis 
  
(Ogungbe et al., 2011)
 
18 
 
 
Rhynedulin A 
 
R. edulis 
 
 
 
 
 
(Ogungbe et al., 2011)
 
19 
Rhynedulin B 
 
R. edulis 
 
  
(Ogungbe et al., 2011)
 
 
20 
 
 
Rhynedulin C 
 
R. edulis 
 
 
(Ogungbe et al., 2011)
 
 
21 
 
 
 
Cyclochandalone 
 
R. edulis 
 
 
(Ogungbe et al., 2011)
 
 
 
22 
 
Rhynedulina 
 
R. edulis 
 
 
(Ogungbe et al., 2011)
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23 
 
Cajanone 
 
R. edulis 
  
(Ogungbe et al., 2011)
 
 
24 
 
Daidzein 
 
R. volubilis 
 
 
(Li and Xiang, 2011) 
25 
 
Calycosin 
 
R. volubilis 
 
 
(Li and Xiang, 2011) 
26 
 
Biochanin A 
 
R. volubilis 
 
 
(Li and Xiang, 2011)
 
27 
 
Pratensein 
 
R. volubilis 
 
 
(Li and Xiang, 2011)
 
28 
 
3-[4′-(1′-methoxy)-propoxy]-phenyl-5,7- 
dihydroxyisoflavone 
 
R. volubilis 
 
 
(Li and Xiang, 2011)
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Table 2.3.3: Flavonols 
 
S/No. Chemical structure and name of  isolated compound Plant 
source(s) 
Biological 
activity 
Reference(s) 
29 
 
Rutin/Rutoside 
 
R. beddomei 
R. hirta 
 
 
 
 
(Adinarayana et al., 1985) 
(Adinarayana et al., 1980c) 
 
(Adinarayana et al., 1980a) 
 
30 
 
Kaempferol-3-O-rutinoside/Nicotiforin 
 
R. hirta 
 
  
(Adinarayana and Chetty, 
1985) 
 
(Adinarayana et al., 1980a) 
 
31 
 
 
6,7,4′-trihydroxyflavonol 
 
R. beddomei 
  
(Adinarayana et al., 1980b)
 
32 
 
Kaempferol 
 
R. rufescens 
  
(Adinarayana and 
Ramachandraiah, 1984) 
33 
 
3-O-methylquercetin 
 
R. rufescens 
  
(Adinarayana and 
Ramachandraiah, 1984) 
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34 
 
5-deoxygaletin 
 
R. beddomei 
 
  
(Adinarayana et al., 1980b) 
 
35 
 
5-deoxyquercetagetin/Rhynchosin 
 
R. beddomei 
 
  
(Adinarayana et al., 1980b) 
 
36 
 
Fisetin 
 
R. beddomei 
 
  
(Adinarayana et al., 1980b) 
 
37 
 
Robinetin 
 
R. beddomei 
 
  
(Adinarayana et al., 1980b) 
 
38 
 
7,4′-dihydroxyflavonol 
 
R. beddomei 
 
  
(Adinarayana et al., 1980b) 
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39 
 
8-C-prenylquercetin-7,4′-dimethyl ether/Rhynchospermin 
 
R. hirta 
 
 
 
 
 
(Adinarayana et al., 1981)
 
 
 
Table 2.3.4: Flavan-3-ols 
 
 
S/No. Chemical structure and name of  isolated 
compound  
Plant 
source(s) 
Biological 
activity 
Reference(s) 
40 
 
 
Epicatechin 
 
R. volubilis 
 
 
 
 
(Li and Xiang, 2011) 
41 
 
7-O-galloylcatechin 
 
R. volubilis                    
 
Antiproliferative 
activity 
 
(Kinjo et al., 2001) 
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Table 2.3.5: Flavanonols 
 
S/No. Chemical structure and name of  
isolatedcompound  
Plant 
source(s) 
Biological 
activity 
Reference(s) 
42 
 
 
6-C-prenyltaxifolin-7,3′-dimethylether/Isotirumalin 
 
R. densiflora    
R. hirta 
 
 
 
 
 
(Rao and Gunasekar, 1998) 
(Rao and Gunasekar, 1988) 
43 
 
 8-C-prenyltaxifolin-7,4'-dimethyl ether/Tirumalin 
 
R. hirta 
 
  
(Adinarayana et al., 1985) 
(Adinarayana et al., 1980a)
 
 
Table 2.3.6: Flavanone(s) 
 
S/No. Chemical structure and name of  
isolatedcompound  
 Plant source(s) Biological 
activity 
Reference(s) 
44 
 
 
Naringenin 
 
R. beddomei 
 
 
 
 
 
 
(Adinarayana et al., 1980c) 
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Group 2: Miscellaneous; 
Table 2.4.1: Phenolic acids  
 
S/No. Chemical structure and name isolated 
compound  
Plant 
source(s) 
Biological 
activity 
Reference(s) 
45 
 
 
Gallic aid 
 
R. volubilis  
 
R. minima 
 
 
Antiproliferative 
activity 
 
(Kinjo et al., 2001) 
 
(Krishnamurty et al., 
1975) 
46 
 
4-hydroxy-3-methoxybanzoic acid/Vanillic acid 
 
R. hirta 
 
 
  
(Adinarayana et al., 1985) 
 
47 
 
 
3-hydroxy-5-methoxy-4-(3-methyl-2-butenyl)-2-
biphenylbenzoic acid 
 
R. suaveolens 
 
 
Antibacterial 
 
(Khan and Shoeb, 1984) 
48 
 
 
Protocatechuic acid 
 
R. minima 
 
 
 
 
 
 (Krishnamurty et al., 
1975) 
 
 
49 
 
Glucogallin 
 
R. volubilis 
 
 
Antiproliferative 
activity 
 
(Kinjo et al., 2001) 
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50 
 
 
Gallic acid ethyl ester 
 
R. minima 
 
 
 
 
 
(Krishnamurty et al., 
1975) 
51 
 
Gallic acid methyl ester 
 
R. volubilis 
 
Antiproliferative 
activity 
 
(Kinjo et al., 2001) 
 
52 
 
Trigallic acid 
 
R. volubilis 
 
Antiproliferative 
activity 
 
(Kinjo et al., 2001) 
 
 
Table 2.4.2: Xanthones 
 
S/No. Chemical structure and name of isolated 
compound 
Plant source(s) Biological 
activity 
Reference(s) 
53 
 
 
 
Mangiferin 
 
R. suaveolens 
 
 
Radical 
scavenging 
activity 
 
 
(Rammohan et al., 2015) 
 
(Adinarayana and Chetty, 
1985)
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54 
 
Isomangiferin 
 
R. suaveolens 
 
  
(Adinarayana and Chetty, 
1985) 
 
Table 2.4.3: Sterols 
 
S/No. Chemical structure and  name of isolated 
compound 
Plant 
source(s) 
Biological 
activity 
Reference(s) 
55 
 
 
β-sitosterol 
 
R. minima 
 
 
 
 
(Ahmed et al., 1992) 
(Krishnamurty et al., 1975) 
 
56 
 
Stigmasteryl galactoside  
 
R. minima 
 
  
(Ahmed et al., 1992) 
 
57 
 
 
Lupeol 
 
R. minima 
 
 
 
 
(Ahmed et al., 1992) 
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Table 2.4.4: Galloyl derivative(s) 
 
Table 2.4.5: Simple aromatic natural products 
 
S/No. Chemical structure and name of  isolated 
compound 
Plant 
source(s) 
Biological 
activity 
Reference(s) 
59 
 
 
3-hydroxy-5-methoxy-4-(3-methyl-2-
butenyl)biphenyl 
 
R. suaveolens 
 
 
Antibacterial 
 
 
(Khan and Shoeb, 1984) 
60 
 
2-hydroxy-3,4- dimethoxybenzophenone 
 
R. suaveolens 
 
 
 
 
(Rammohan et al., 2015) 
61 
 
 
Hydroquinone diacetate 
 
R. minima 
 
 
 
(Krishnamurty et al., 1975) 
 
S/No. Chemical structure and name of isolated 
compound 
Plant source(s) Biological activity Reference(s) 
58 
 
1,6-digalloly glucose 
 
R. volubilis                    
 
Antiproliferative 
activity 
 
 
(Kinjo et al., 2001)
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Table 2.4.6: Simple non-aromatic natural products 
 
*R: Rhynchosia, Glu: glucose, R. hirta = R. cyanosperma, spp: unspecified species 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S/No. Chemical structure and name of isolated 
compound 
Plant source(s) Biological 
activity 
Reference(s) 
62 
 
D-pinitol 
 
R. beddomei 
R. hirta 
 
 
 
(Adinarayana et al., 1979) 
(Adinarayana et al., 1980a) 
 
63 
 
D-inositol 
 
R. spp. 
R. beddomei 
  
(Allen and Allen, 1981) 
 
(Adinarayana et al., 1980c) 
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3.1 METHODS AND MATERIALS 
 
3.1.1 CHEMICAL REAGENTS 
 
Methanol (MeOH), ethyl acetate (EtOAc), ethanol (EtOH), hexane (Hex), dichloromethane 
(DCM), and dimethyl sulfoxide (DMSO) were secured from Merck (S. Africa). The mushroom 
tyrosinase (EC 1.14.18.1) 5771 Unit/mg, L-tyrosine, kojic acid and deuterated methanol 
(CD3OD) were purchased from Sigma Aldrich (S. Africa). 
 
3.1.2 THIN LAYER CHROMATOGRAPHY (TLC) 
 
Pre-coated TLC plates of silica gel 60 F254 [Merck (Darmstadt; Germany)] were used for TLC 
analysis using a UV lamp of            nm [CAMAG (Muttenz; Switzerland)] to visualize the 
„spots‟ or bands after developing the TLC plates in various solvent systems. Chemical detection 
was performed after spraying with vanillin/H2SO4 reagent and heating at 110 . 
 
3.1.3 COLUMN CHROMATOGRAPHY (CC) 
 
Silica gel 60 (0.040 – 0.063 mm) (Merck Millipore; S. Africa) and sephadex LH-20 (Sigma 
Aldrich; S. Africa) were used in various sizes of glass columns. 
 
 
 
CHAPTER THREE 
COLLECTION/EXTRACTION AND CHEMICAL CHARACTERIZATION 
OF BIOACTIVE COMPOUNDS FROM TRADITIONALLY USED HERBAL 
MEDICINE FOR TREATMENT OF HYPERPIGMENTATION 
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3.1.4 HIGH PERFOMANCE LIQUID CHROMATOGRAPHY (HPLC) 
 
For semi-prep HPLC purification, a HPLC „1200 series‟ (Agilent Technologies) comprising a 
variable wavelength UV/Vis detector, manual injector, quaternary pump (G1311A), vacuum 
degasser (G1322A), column compartment (G1316A) and reversed phase C18 column SUPELCO 
(25   2.1 cm, 5  m) was used. The used mobile phase was MeOH-deionized H2O (DIW) (55:45 
to 70 % in 30 min, then to 100 % in 5 min) and the flow rate employed was 1.0 mL/min. 
 
3.1.5 NUCLEAR MAGENETIC RESONANCE SPECTROSOPY (NMR) 
 
Deuterated methanol (CD3OD) was used to prepare the samples for NMR. NMR spectra were 
recorded at 25  on a Bruker Avance III HD 400 MHz NMR spectrometer (Germany) using a 5 
mm BBO probe. Standard 1D and 2D NMR pulse sequences were used to acquire 1D and 2D 
data respectively. The 
1
H (  ) and 
13
C (  ) chemical shifts were measured comparatively to 
CD3OD signals at 3.23, 4.78 (
1
H NMR) and 48.3 (13C NMR) in ppm. 
 
3.1.6 TYROSINASE ENZYME INHIBITION 
 
The skin enzymatic inhibitory assay was executed in the course of the study following the 
approach used by Vanni et al. (1990), with slight modification (Popoola et al., 2015). Initially, a 
stock solution of 10 mg/mL was prepared by dissolving the plant extracts to be tested in dimethyl 
sulfoxide (DMSO), then 5 dilutions were performed using 50 mM sodium phosphate buffer (pH 
6.5) for all working solutions to obtain the working concentrations of 100.00, 50.00, 25.00, 
12.50, and 6.25 μg/mL, respectively. Kojic acid was used as a positive control in this assay. Each 
sample working solution of 70 μL was combined with 30 μL of tyrosinase [from mushroom, 500 
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Unit/mL in sodium phosphate buffer (pH 6.5)] in triplicate, in a 96-well plate. After incubation at 
room temperature for 5 min, 110 μL of the substrate (2 mM L-tyrosine) was added to each well. 
Final concentrations of the positive control, crude extracts and/or isolated compounds ranged 
from 1.0 - 100 μg/mL. The sample control was made up of each sample using sodium phosphate 
buffer (pH 6.5) only. The enzymatic activity was determined by measuring the absorbance at 490 
nm using AccuReader M965 microplate reader (Metertech; Taiwan). The measurements were 
recorded immediately after incubation was carried out at room temperature (25 ) for 
approximately 30 min. Equation 1 was employed in determining the percentage of tyrosinase 
inhibition.  
Equation 1: Percentage of tyrosinase inhibition; 
 
 
Where          is the absorbance of the control with the enzyme,          is the absorbance of 
the control without the enzyme,         is the absorbance of the test sample with the enzyme 
and          is the absorbance of the test sample without the enzyme. 
 
3.1.7 TLC BIOAUTOGRAPHY 
 
TLC bioautograpy was carried out as described by Wangthong et al. (2007), with slight changes. 
Initially, the tyrosinase solution was prepared by dissolving 1 mL of the 1000 Unit enzyme in 1 
mL of 50 mM sodium phosphate buffer (pH 6.5). The substrate was also prepared by dissolving 
0.0036 g of L-tyrosine in 10 mL of 50 mM sodium phosphate buffer (pH 6.5). Then, the positive 
control, crude extracts and/or main fractions were dissolved in methanol to prepare a stock 
% of tyrosinase inhibition  
(                 )  (                 )
(                 )
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solution of 1 mg/mL. The kojic acid, crude extracts and/or main fractions solutions were then 
spotted on the TLC plate and eluted with DCM-MeOH [(95:5) and/or (90:10)]. The developed 
plate was then sprayed with tyrosinase enzyme and incubated at a room temperature for 5 min. 
After incubation, it was sprayed with L-tyrosine (20 mM) and once again incubated at room 
temperature for 30 min. Indication of the presence of tyrosinase inhibitory activity amongst the 
investigated samples was shown by clear white zones as the background of the plate assumed a 
purple-greyish colour. 
3.1.8 STATISTICAL ANALYSIS 
 
The tyrosinase enzyme inhibitory effect of the plant extracts, isolated compounds and kojic acid 
were assayed in triplicate. The final values of the tyrosinase skin enzymatic inhibition assay were 
expressed as IC50 values and determined using the GraphPad Prism 5.0 software. For all 
analyses, p < 0.05 was considered to indicate a statistically significant difference. 
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3.2 ACQUISITION AND AUTHENTICATION OF PLANT MATERIALS 
 
3.2.1 COLLECTION OF PLANT MATERIALS 
 
The collection of the plant materials examined in the study was done by the late Mr Zekanzima 
Ndzoyiya and Mr Solomon Kuca from Ntsubane forest complex in Lusikisiki (E. Cape 
Province), during November 2015. Lusikisiki is located approximately 40 km north of Port St. 
Johns (Figure 3.1); it is characterized by spectacular views of natural vegetation and waterfalls 
(South African Traveler, 2015). The Ntsubane forest complex is a perpetual evergreen forest, 
situated on the periphery of the Indian Ocean. The voucher specimens examined in the study 
were authenticated by Dr. Christopher Cupido (SANBI; Kirstenbosch, S. Africa). 
 
Retrived from  Zoologische mededelingen wbsite:http://www.zoologischemededelingen.nl/83/nr03/a06 
Figure 3.1: Location of Lusikisiki in the E. Cape Province (S. Africa). 
 
Map 8 
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3.2.2 INVESTIGATED PLANT SPECIES AND RELATIVE INFORMATION 
 
Fifteen interviews were conducted with fifteen traditional healers within the E. Cape Province, 
particularly in the Pondoland (Mthatha, Libode, Port St. Johns, and Lusikisiki), to obtain 
ethnomedicinal knowledge and relative importance of various indigenous medicinal plants which 
are used in healing skin disorders and hyperpigmentation disorders, in particular. Ten plant 
species from various families were commonly suggested by the interviewed traditional healers. 
Such plant species and the relative information are shown in Table 3.1. 
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Table 3.1: Investigated plant species and their relative information 
 
No. Scientific 
name 
Family Herbarium 
number 
Local name English 
name 
Part 
used 
 Endemism Traditional uses Reference(s) 
1 
 
 
Cassine peragua 
L. 
 
Celastraceae 
 
NBGSLD0001440 
 
Umbomvane 
 
Cape saffron 
 
Bark 
 
Endemic to 
Southern 
Africa  
 
Traditionally used for treating 
burns. 
 
— 
2  
Cassipourea 
gummiflua Tul.  
 
Rhizophoracea 
 
NH0006334-0 
 
 
Umemezi 
 
Large-leaved 
onionwood 
 
Bark 
 
Not endemic 
to South 
Africa  
Is used as a substitute of 
Cassipourea malosana as skin 
lightener, and to treat skin ailments 
and sunburn. Also used for 
protection from evil spirits. 
 
(Brink, 2006) 
3  
Clivia miniata 
(Lindl.) Bosse  
 
Amaryllidaceae 
 
PREART0003332 
 
Umayime 
 
Bush lily 
 
Root 
rhizome 
 
Endemic to 
Southern 
Africa  
The rhizome is taken for snake-
bite, wounds and pain relief. While 
whole plant is used to help with 
childbirth and to hasten parturition. 
 
(Tait, 2001) 
4 Cryptocarya 
myrtifolia Stapf 
 
Lauraceae 
 
SAM0043557-0 
 
Umthungwa 
 
Camphor tree 
 
Stem 
bark 
 
Endemic to 
South Africa  
Used interchangeable with the bark 
of Ocotea bullata internally as in 
form of tea or applied as steam 
(external use) to treat pimples. 
(Hutchings et al., 
1996)
 
(Van Wyk and 
Van Wyk, 1997)
 
5 Gunnera 
perpensa L. 
 
Gunneraceae 
 
K000350081 
 
Uphuzi 
lomlambo 
 
River 
pumpkin 
 
Rhizome 
Not endemic 
to South 
Africa 
Externally used as a wound 
dressing. Infusions may be taken 
internally to treat psoriasis. 
(Mabona and van 
Vuuren, 2013) 
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6   
Kigelia africana 
(Lam.) Benth. 
 
Bignoniaceae 
 
PRE0181079-0 
 
Umfongothi 
 
Sausage tree 
 
Fruit 
Not endemic 
to South 
Africa 
Used for various skin disorders 
from fungal infections, boils, acne 
and psoriasis, dressing wounds and 
sores. 
 
(Saini et al., 
2009) 
7 Protorhus 
longifolia 
(Bernh.) Engl. 
 
Anacardiaceae 
 
BNRH0010636 
 
Uzintlwa 
 
Red beech 
 
Bark 
Not endemic 
to South 
Africa 
Used for blood-clotting related 
diseases. 
 
(Mosa et al., 
2011) 
8  
Rapanea 
melanophloeos(L
.) Mez 
 
Myrsinaceae 
 
PRE0822924-0 
 
Maphipha 
 
Cape beech 
 
Bark 
 
Endemic to 
Southern 
Africa 
The plant species is mainly used as 
a charm to protect against evil 
spirits. Its powder form bark is 
internally used (chewed) and/or 
externally used to treat sore throats 
and wounds. 
 
(Van Wyk et al., 
1997) 
9  
Rhynchosia 
villosa 
(Meissner) 
Druce 
 
Fabaceae 
 
PREART0003226 
 
 
Uphuzi lobala 
 
— 
 
Root 
 
Endemic to 
South Africa  
It is used externally and internally 
to enhance the skin texture and 
tone, while it also aid in treating 
swollen parts of the body when 
washed with its soaked leaves. 
Also used in hormone-dependent 
diseases. 
 
— 
10  
Senecio 
serratuloides 
DC. 
 
Asteraceae 
 
NHSLD0002401 
 
Ntsukumbini 
 
Two-day cure 
 
 
Leaves 
 
Not endemic 
to South 
Africa 
Tea made from the leaves is taken 
in case of infections; leaves are 
applied directly to purulent sores. 
Leaf decoction is taken as a blood 
purifier in case of skin eruptions, 
while powdered leaves or roots are 
applied to burns or sores. 
(De Wet et al., 
2013)
 
(Kelmanso et al., 
2000)
 
*The plants were collected from Lusikisiki by Mr Z. Ndzoyiya and Mr S. Kuca, except Kigelia african (10) which was collected from Eerste Rivier by Ms 
Luveni Sonka. 
http://etd.uwc.ac.za/
  
50 
 
3.3 INVESTIGATION OF TYROSINASE INHIBITION OF CRUDE EXTRACTS 
 
3.3.1 TYROSINASE ENZYME INHIBITION OF CRUDE EXTRACTS  
  
The tyrosinase enzyme inhibition assay was used for the preliminary bio-evaluation of the crude 
extracts and was carried out as described in Section 3.1.6. Kojic acid was used as a positive 
control in the assay since the inhibition exerted by kojic acid is well established due to its ability 
to chelate to copper in the active sites of the enzyme (Kubo et al., 2000). Table 3.2 and Figure 
3.2 show the average percentages of tyrosinase inhibition of the investigated plant species 
screened at various concentrations. 
Table 3.2: Average percentages of tyrosinase inhibition (%) and detectable anti-tyrosinase IC50 
values of the different plant extracts 
 
  
 
No. 
 
 
Plant  
extract  
code 
Plant extract 
name 
Average percentages of tyrosinase inhibition (%) in various concentrations 
(μg/mL) and detectable anti-tyrosinase IC50 value of the plant extracts 
100 μg/mL 50 μg/mL 25 μg/mL 
12.5 
μg/mL 
6.25 
μg/mL 
IC50 
(μg/mL) 
1 CM Clivia miniata 29.00 10.27 8.14 7.84 6.93 NA 
2 PL Protorhus longifolia 41.63 38.96 33.33 32.88 31.28 NA 
3 RV 
Rhynchosia villosa 
(roots) 56.40 55.78 49.16 45.28 36.00 15.67 
4 GP Gunnera perpensa 14.31 9.59 6.09 5.18 3.20 NA 
5 CR 
Cryptocarya 
myrtifolia 27.40 23.82 19.63 18.65 18.26 NA 
6 RM 
Rapanea 
melanoploes 52.51 47.79 38.89 37.21 30.82 26.30 
7 Ko Kojic acid 98.47 97.40 97.33 89.48 86.98 0.9 
8 SS Senecio serratuloides 40.87 39.80 24.73 20.70 16.82 NA 
9 RVleaves 
Rhynchosia villosa 
(leaves) 34.55 17.12 16.02 13.85 10.27 NA 
10 CG 
Cassipourea 
gummiflua 17.05 16.29 12.18 6.01 5.72 NA 
11 CP Cassine peragua 29.30 24.80 24.12 16.82 15.91 NA 
12 KA Kigelia africana 39.04 28.39 22.83 20.47 17.50 NA 
*NA: Not active in tested concenration range 
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Figure 3.2: Bar graph depicting average percentages of tyrosinase inhibition (%) of Clivia 
miniata (CM), Protorhus longifolia (PL), Rhynchosia villosa root (RV), Gunnera perpensa (GP), 
Cryptocarya myrtifolia (CR), Rapanea melanophloeos (RM), kojic acid (Ko), Senecio 
serratuloides (SS), Rhynchosia villosa leaves [RV(leaves)], Cassipourea gummiflua (CG), 
Cassine peragua (CP), and Kigelia africana (KA) extracts screened at various concentrations 
(μg/mL). 
 
3.3.2 TLC BIOAUTOGRAPHY OF CRUDE EXTRACTS 
 
To confirm the results obtained in Section 3.3.1, a qualitative approach was performed, i.e., that 
of TLC bioautography. This is a method that combines chromatographic separation and in situ 
biological activity determination. It was employed in the preliminary screening of natural 
products which are anticipated to have the tyrosinase enzyme inhibitory effect and for the 
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bioactivity-directed fractionation and isolation of active constituents from complex fractions 
(Cheng and Wu, 2013). The assay was executed as described in Section 3.1.7. 
Figure 3.3: TLC chromatograms of Clivia miniata (CM), Protorhus longifolia (PL), Rhynchosia 
villosa root (RV), Gunnera perpensa (GP), Cryptocarya myrtifolia (CR), Rapanea 
melanophloeos (RM), Rhynchosia villosa leaves (RVL), kojic acid (Ko),  Cassipourea gummiflua 
(CG), Cassine peragua (CP), and Kigelia africana (KA) extracts developed in solvent system 
DCM-MeOH (95:5), A: viewed under UV (366 nm), B: after spraying with vanillin/H2SO4, 
heating at 110  and viewed under UV (254 nm), C: after spraying with tyrosinase enzyme and 
tyrosine. 
 
According to Figure 3.3, it became apparent that the plant extract of RV (R. villosa root) was the 
most active, since it had clearly developed white zones of tyrosinase inhibition compared to 
other extracts, after spraying with both tyrosinase enzyme and tyrosine (C), respectively. This 
was the indication of the presence of bioactive constituents that are capable of inhibiting 
tyrosinase enzyme. Hence, R. villosa was chosen for further chromatographic study to isolate 
bioactive compounds. 
A B C 
RV 
Kojic acid 
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3.3.3 DISCUSSION OF THE ANTI-TYROSINASE INHIBITION OF THE INVESTIGATED 
PLANT EXTRACTS 
 
Collection of the nine plant species 1–9 (Table 3.1), which are traditionally used for maintaining 
the skin structural integrity and healing skin hyperpigmentation was done in Lusikisiki 
(Ntsubane forest complex) within the E. Cape Province, while plant species 10 (Table 3.1) was 
collected in Eerste Rivier, which is situated in the W. Cape Province. Initial steps taken prior to 
the actual execution of the experiments were carried out using the extracts obtained of the 
suggested plants which included the bio-evaluation of the plant extracts against the tyrosinase 
enzyme (Figure 3.2 and Figure 3.3). 
The results of the skin enzyme inhibitory assay showed that two plant species, namely, 
Rhynchosia villosa root and Rapanea melanoploes bark inhibited tyrosinase enzyme (Figure 3.2 
and Figure 3.3). R. villosa was found to be the most active extract, as it inhibited mushroom 
tyrosinase with IC50 value of 15.67 µg/mL, while R. melanoploes inhibited mushroom tyrosinase 
with IC50 value of 26.3 µg/mL. Hence R. villosa was chosen for further chromatographic study, 
in order to isolate the bioactive compounds. 
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3.4 DESCRIPTION AND DISTRIBUTION OF R. VILLOSA 
 
3.4.1 DESCRIPTION OF R. VILLOSA 
 
As mentioned previously, R. villosa is one of the Fabaceae species. Like many legumes, R. 
villosa is a trailing plant species with hairy petioles, stems and leaves. The flowers of the 
inflorescence are yellow in colour with red veins, its pinnately compound leaves are light-green 
and they assume peltate shape. It consists of perennial underground system, an erect rootstock 
(Figure 3.4), which is the traditional used part for skin depigmentation. Both the rootstock and 
the leaves of R. villosa were bioevaluated in the study against the tyrosinase enzyme, where the 
rootstock showed higher tyrosinase inhibitory activity than the leaves (Section 3.3); this 
substantiated its preference in traditional use for skin depigmentation instead of the leaves. 
 
Figure 3.4: Illustration of the rootstock of R. villosa. 
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3.4.2 DISTRIBUTION OF R. VILLOSA 
 
As denoted in Table 3.1, R. villosa is endemic to S. Africa and widely distributed in KZN, 
Mpumalanga Province and E. Cape Province (Figure 3.5) (Foden and Potter, 2005). 
  
 
 
Map 9:  Retrieved from Red List of South Africa Plants website: http://redlist.sanbi.org/species.php?species=370-90 
Figure 3.5: Distribution of R. villosa and its description.
Map 9 
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3.5 EXTRACTION AND FRACTIONATION OF R. VILLOSA ROOT 
 
3.5.1 EXTRACTION OF R. VILLOSA ROOT 
 
The R. villosa root (RV) with a mass of 131.2 g was initially grated to small shreds before it was 
allowed to extract in 500 mL of MeOH for 48 hours. The mixture was then filtered and the 
combined filtrates were concentrated under reduced pressure at 40 . The crude extract was then 
weighed [15.11 g (11.5 % of the raw material)] and kept at approximately 0 . 
 
3.5.2 COLUMN CHROMATOGRAPHY OF THE CRUDE EXTRACT 
 
The crude extract of R. villosa (15 g) was applied to a silica gel column and eluted with 
Hex:EtOAc (6.6 L:7.4 L) and EtOAc:MeOH (3.85 L:1.15 L) gradient mixtures of increasing 
polarity as shown in Table 3.3. 
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Table 3.3: Fractionation of the methanolic extract of R. villosa (15 g) 
 
SOLVENT SYSTEM 
VOLUME (L) FRACTIONS Hex:EtOAc   
100:0 0.5 1-2 
90:10 1 3-6 
80:20 1 7-10 
70:30 2 11-18 
60:40 2 19-26 
50:50 2 27-34 
30:70 2 35-42 
10:90 2 43-50 
0:100 1.5 51-56 
EtOAc:MeOH                
          95:5                 1 55-58 
90:10 1 59-62 
80:20 1 63-66 
70:30 1 67-70 
50:50 1 71-74 
 
Fractions of 250 mL were collected (Figure 3.6). Similar fractions were combined according to 
their TLC profile to obtain 20 main fractions (Table 3.4). 
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Figure 3.6: TLC chromatograms of fractions obtained from column chromatography of R. 
villosa methanolic extract,  
adsorbent: silica gel                                                                                                               
solvent systems: D [Hex:EtOAc (7:3)]; E [Hex:EtOAc (1:1)]; F [DCM:MeOH(9:1)];                
G [DCM:MeOH:H2O (85:15:0.5)]                                                                                     
detection: sprayed with vanillin/H2SO4 and heated at 110 . 
D E 
F G 
Hex : EtOAc 
7 : 3 
 
Hex : EtOAc 
1 : 1 
 
DCM : MeOH 
9 : 1 
 
DCM : MeOH : H2O 
85 : 15 : 0.5 
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Table 3.4: Main fractions of R. villosa methanolic extract 
 
 
 
 
 
COMBINED 
FRACTIONS 
DESIGNATED 
CODE MASS (mg) 
1-2 I 5.1 
3 II 75.7 
4-5 III 79.7 
6-7 IV 94.5 
8-9 V 46.3 
10-12 VI 153.9 
13-14 VII 28.8 
15-16 VIII 1.2 
17-21 IX 118.3 
22-25 X 83.0 
26-28 XI 10.0 
29-31 XII 61.5 
32-34 XIII 324.2 
35-41 XIV 242.0 
42-48 XV 163.8 
49-53 XVI 612.4 
54-59 XVII 4399.4 
60-63 XVIII 5295.7 
64-67 XIX 583.4 
68-70 XX 288.4 
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3.5.3 QUALITATIVE SCREENING OF THE MAIN FRACTIONS USING TLC 
BIOAUTOGRAPHY 
 
The main fractions (I-XV) obtained from the main column were spotted on TLC plates (2 copies) 
and developed in DCM:MeOH (9:1). One of the plates (H) was sprayed with vanillin/H2SO4 and 
other plate (I) was sprayed with the tyrosinase enzyme and tyrosine, as explained in Section 
3.1.7. Figure 3.7 shows the two plates and the inhibition zones in plate I, which indicated 
bioactivity, showing that fractions IX-XV contained the most active compounds. 
 
Figure 3.7: TLC chromatograms of the main fractions (I-XV) spotted on TLC plates and 
developed in DCM:MeOH (9:1), plate H: sprayed with vanillin/H2SO4 and heated at 110 , 
plate I: sprayed with tyrosinase and L-tyrosine. 
 
H I Activefractions Activefractions Kojicacid 
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3.6 ISOLATION OF THE CHEMICAL CONSTITUENTS OF R. VILLOSA 
 
3.6.1 COLUMN CHROMATOGRAPHY OF MAIN FRACTION IX 
 
Fraction IX (118.3 mg) was applied onto a sephadex column and eluted with a 5 % aqueous 
EtOH solution. Similar fractions were combined together to give the sub-fractions IX1 – IX5 
(Table 3.5; Figure 3.8). 
Table 3.5: Collective sub-fractions from the fractionation process of the main extract IX 
 
  
 
 
 
 
 
 
 
 
  
COMBINED 
FRACTIONS 
DESIGNATED 
CODE MASS (mg) 
1-12 Discarded — 
13-23 IX1 1.1 
24-31 IX2 15.2 
32-34 IX3 46.1 
36-37 IX4 49.8 
38-44 IX5 6.1 
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Figure 3.8: TLC chromatogram of the sub-fractions of main fraction IX viewed under UV (254 
nm; J) and after vanillin spraying and heating at 110  (K). 
 
In order to determine the content and purity of the obtained active compounds and their 
molecular structures, the samples were subjected to NMR spectroscopy. Thus, it was confirmed 
from the NMR spectrometer that sub-fraction IX3 and IX5 were pure compounds. The samples 
were isolated with a mass of 46.1 mg (IX3; 0.035 %) and 6.1 mg (IX5; 0.0046 %), respectively. 
 
 
 
 
 
J K IX3 
IX5 
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3.6.2 HPLC CHROMATOGRAPHY OF MAIN FRACTION X 
 
As indicated in Figure 3.7, the main fraction X was amongst the fractions that showed the 
highest tyrosinase inhibitory activity. This fraction was initially dissolved in MeOH, before it 
was injected in the HPLC. A gradient solvent system of MeOH:DIW (55:45 to 70 % in 30 min, 
then to 100 % in 5 min) was used as the eluent. HPLC of fraction X (83 mg) afforded one 
prominent peak (Figure 3.9), which was collected and labelled X1 (4 mg; 0.0030 %).  
 
Figure 3.9: HPLC chromatogram (L) of the afforded peak X1, and TLC chromatogram after 
spraying with vanillin/H2SO4 and heating at 110  (M). 
 
*Conditions used: 
Solvent MeOH:DIW (55:45 to 70 % in 30 min, then to 100 % in 5 min) 
Column SULPECO, RP-18 (25   2.1 cm) 
Flow rate 1.0 mL/min 
Detection UV at 254 nm 
L 
L 
M 
X1 
X1 
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3.6.3 COLUMN CHROMATOGRAPHY OF MAIN FRACTIONS (XIV AND XV) 
 
Sephadex fractionation of the two main fractions, viz. XIV and XV with a combined mass of 406 
mg was performed. According to the results of the TLC bioautography method which was 
employed for bioactivity-directed fractionation of the main fractions of R. villosa (Figure 3.7), 
these two polar fractions were found to be amongst active fractions against the tyrosinase 
enzyme. The combined fraction was applied to a sephadex column using 5 % aqueous EtOH. 
Two pure compounds labelled XIV4 (5.9 mg; 0.0045 %) and XIV6 (287.4 mg; 0.22 %) (Table 
3.6; Figure 3.10) were isolated. 
Table 3.6: Collective sub-fractions from fractionation of the combined main fractions (XIV and 
XV) 
 
 
 
  
 
 
 
 
 
COMBINED 
FRACTIONS 
DESIGNATED 
CODE MASS (mg) 
1-30 Discarded — 
31-38 XIV1 6.0 
39-42 XIV2 8.5 
43 -54 XIV3 68.6 
55-58 XIV4 5.9 
59-61 XIV5 20.1 
62-75 XIV6 287.4 
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Figure 3.10: TLC chromatogram of the sub-fractions of combined main fractions (XIV and XV) 
after spraying with vanillin/H2SO4 and heating at 110  (N). 
 
The compounds were thoroughly characterized using NMR spectroscopy. According to the 
1
H 
and 
13
C NMR data obtained, the two polar sub-fractions (XIV4 and XIV6) indicated in Figure 
3.10 were found to be pure compounds.   
 
 
 
 
N 
XIV6 
XIV4 
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3.6.4 SUMMARY OF THE ISOLATION AND PURIFICATION OF CONSTITUENTS FROM 
R. VILLOSA 
 
As pointed out in Section 3.6.1 – 3.6.3, five compounds viz. IX3, IX5, X1, XIV4 and XIV6 were 
isolated from four active main fractions (IX, X, and combined fractions XIV and XV; Figure 3.7) 
of R. villosa. To avoid inconvenience, the isolated compounds (IX3, IX5, X1, XIV4 and XIV6) 
were labelled C1, C2, C3, C4 and C5 from here on respectively. Scheme 3.1 shows the 
summary of the isolation and purification of constituents from R. villosa. Hence both C1 and C2 
were isolated from fractionation of main fraction IX through sephadex open column. Same 
applies with C4 and C5; they were isolated from fractionation of combined main fractions (XIV 
and XV) with aid of sephadex open column. While C3 was afforded from fractionation of main 
fraction X via semi-prep HPLC. 
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                   INACTIVE FRACTIONS                                                                     ACTIVE FRACTIONS 
  
 
 
 
 
 
 
  
 
 
 
 
 
Scheme 3.1: Experimental procedure of the isolation and purification of constituents from R. villosa. 
  
Rhynchosia villosa MeOH extract (15 g) 
MAIN OPEN COLUMN 
Silica gel, Hex:EtOAc (100:0 – 0:100)  
)  
IX  
118 mg 
XIV+XV 
406 mg 
OPEN COLUMN      
(Sephadex, 5 % aqueous EtOH) 
OPEN COLUMN       
(Sephadex, 5 % aqueous EtOH) 
HPLC FRACTIONATION 
(MeOH-deionized H2O) 
IX3 
46.1 mg 
IX3=C1 
 
 
XIV6 = C5 
XIV4= C4 
 
X1= C3 
 
X  
83 mg 
IX5 
6.1 mg 
 
IX5 = C2 
X1 
4 mg 
VIII 
1 mg 
VII 
29 mg 
VI 
154 mg 
V 
46 mg 
IV 
95 mg 
III 
80 mg 
80 mg 
II 
76 mg 
I 
5 mg 
XIV6 
287 mg 
XIV4 
5.9 mg 
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4.1 STRUCTURE ELUCIDATION OF ISOLATED ISOFLAVONES 
 
Structure elucidation of genistein (C1): 
 
One-dimensional NMR experiments are fundamental in determining the resonance frequency of 
each 
1
H or 
13
C nucleus in the molecule, thus, both 
1
H and 
13
C NMR experiments were employed 
the most in elucidating the structures of the isolated compounds in the current study.  Moreover, 
the chemical shifts obtained gave important information about the nature and number of protons 
and carbons in the compounds of interest. The recorded chemical shifts were then validated by 
comparing them with existing literature data (Pinheiro and Justino, 2012).   
 
Genistein (C1) 
Figure 4.1: Chemical structure of genistein (C1). 
  
Compound IX3 (46.1 mg; 0.035 %), was isolated as an amorphous yellow powder, showing a 
characteristic flavonoid nature using UV-Vis light (TLC) and the NMR data obtained. Its 
spectral data was correlated with the existing literature data (Yoon et al., 2016). The 
1
H NMR 
spectrum (Figure 4.2; Table 4.1) showed aromatic protons of ring A at δH 6.02 [(H-6, d) 2.0 Hz] 
and 6.12 [(H-8, d) 2.0 Hz], while another deshielded olefinic proton was observed and is 
attributed to ring C at δH 7.86 (H-2, s). Signals typically observed for ring B, revealed two pairs 
CHAPTER FOUR 
STRUCTURE ELUCIDATION AND ANTI-TYROSINASEACTIVITY OF 
R. VILLOSA CONSTITUENTS 
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of equivalent aromatic protons, one pair resides at δH 6.72 and 6.74 [(H-3' and H-5', d) 8.8 Hz], 
while the other pair resides at δH 7.23 and 7.25 [(H-2' and H-6', d) 8.8 Hz], which are 
characteristic of a 1,4-disubstituted ring B.  
 
Figure 4.2:
1
H NMR spectrum of compound C1 in CD3OD. 
 
The 
13
C NMR spectrum (Figure 4.3; Table 4.1) depicted twelve aromatic carbons δc 162.2 (C-5), 
100.2 (C-6), 169.1 (C-7), 94.8 (C-8), 157.3 (C-9), 103.6 (C-10), 122.3 (C-1'), 158.6 (C-4'), 130.0 
(C-2' and C-6'), 114.8 (C-3' and C-5') belonging to ring A and B. An olefinic carbon at δc 152.9 
(C-2), quaternary carbon at δc123.0 (C-3) and carbonyl carbon at δc 180.3 (C-4, C=O) were 
observed and are attributed to ring C. The high intensity signals at δC 114.8 and 130.0 were 
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evidence of the presence of the two pairs of equivalent carbons, i.e., C-3' with C-5' and C-2' with 
C-6' positions, respectively. 
 
Figure 4.3:
13
C NMR spectrum of compound C1 in CD3OD. 
 
These data implied the presence of an isoflavone nucleus functionalized with a 5,7,4'-trihydroxy 
group. Careful review of the literature thus confirmed the compound to be genistein, a common 
isoflavone isolated from soybean and widely distributed in Leguminosae. Figure 4.1 shows the 
chemical structure of genistein (C1). 
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Structure elucidation of cajanin (C2): 
 
Elucidation of the chemical structure of C2 was achieved by employing heteronuclear 2D NMR 
experiments (HSQC and HMBC), which generate contour maps that show the correlations 
between proton and carbon nuclei, hence providing an opportunity to observe the 
1
H and 
13
C 
NMR data directly (Claridge, 1999). Two-dimensional NOESY data were also acquired and 
these data are useful at establishing non-bonded connectivity, or connectivity through space 
(Pinheiro and Justino, 2012). 
 
Cajanin (C2) 
Figure 4.4: Chemical structure of cajanin (C2). 
 
Compound IX5 (6.1 mg; 0.0046 %) was isolated as an amorphous yellow powder. The 
1
H NMR 
spectrum (Figure 4.5; Table 4.1) showed two aromatic protons attributed to ring A δH 6.26 [(H-6, 
d) 2.2 Hz], 6.46 [(H-8, d) 2.2 Hz] and three methyl protons δH 3.81 (MeO-7, s) attributed to a 
methoxy functional group. An additional three protons were observed for ring B at δH 6.30 [(H-
3', d) 2.4 Hz], 6.28 [(H-5', dd) 2.4 Hz, 8.4 Hz], and 6.96 [(H-6', d) 8.4 Hz], while one deshielded 
proton was observed to resonate at δH 7.91 (H-2, s) and is attributed to ring C.  
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Figure 4.5:
1
H NMR spectrum of compound C2 in CD3OD. 
 
Significant differences were observed in the 
13
C NMR spectrum (Figure 4.6; Table 4.1) of C2 
when compared to that of C1 as some of the ring B carbons were found to be shielded and this is 
likely due to additional electron density imparted by the hydroxyl group occurred at C-2' 
position. Two carbon signals residing at δc 102.8 (C-3'; ortho) and 106.6 (C-5'; para) were 
highly shielded in comparison to C1, while both C-6' (δc 131.8; meta) and C-4' (δc 158.6; meta) 
were found in the same positions as for C1. As mentioned above, unlike in C1, a deshielded 
carbon signal occurring at δc 156.2 (C-2') indicated the presence of a hydroxyl functional group 
at the C-2' position. Additional carbon signals were observed to resonate at δc 155.6 (C-2), 121, 4 
(C-3), 181.4 (C-4), 162.1 (C-5), 97.9 (C-6), 165.9 (C-7), 91.8 (C-8), 158.3 (C-9), 105.6 (C-10) 
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109.2 (C-1') and 55.1 (MeO-7) accounting for all the expected signals for the structure attributed 
to C2 (Figure 4.4).  
 
 
Figure 4.6:
13
C NMR spectrum of compound C2 in CD3OD. 
 
The NMR spectra of C2 was found to be similar to that of C1, with the main difference being the 
presence of the methoxy signals at δH 3.81/δc 55.1 in 
1
H and 
13
C NMR spectra, respectively, 
indicating the presence of the methoxy group (OMe) at C-7. The position of the methoxy group 
was additionally evidenced from a 2D HMBC spectrum (Figure 4.7) which showed a correlation 
between the O-methyl protons at δH 3.81, to C-7 (δC 165.9).  
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Figure 4.7: HMBC NMR spectrum of compound C2 in CD3OD. 
 
 
Through 
13
C NMR (Figure 4.6) and 2D HSQC spectra (Figure 4.8), we were able to assign 
unambiguously the proton/carbon correlations and other unprotonated signals. 
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Figure 4.8: HSQC NMR spectrum of compound C2 in CD3OD. 
 
In addition, the methoxy group in the 2D NOESY spectrum (Figure 4.9) showed cross peaks 
with H-6 and H-8. The chemical structure of C2 was finally confirmed by comparison with the 
previously reported data (Waffo et al., 2000). Compound C2 was identified as cajanin, a major 
constituent of one of the closely related species to that of Rhynchosia, Cajanus cajan. 
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Figure 4.9: NOESY NMR spectrum of compound C2 in CD3OD. 
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Structure elucidation of 2'-hydroxygenistein (C3): 
 
 
   2'-hydroxygenistein (C3) 
Figure 4.10: Chemical structure of 2'-hydroxygenistein (C3). 
 
Compound X1 (4mg; 0.0030 %) was obtained as a pale-yellow powder, and its spectral data was 
found to be very similar to that of C2, except the methoxy signals were absent. The structure 
elucidation of C3 (Figure 4.10) was carried out by comparing its spectral data with the existing, 
documented data (Awouafack et al., 2011; Lo et al., 2002). The 
1
H-NMR spectrum (Figure 4.11; 
Table 4.1) showed the two deshielded protons residing at δH 6. 14 [(H-6, d) 2.0 Hz], and 6.27 
[(H-8, d) 2.0 Hz] to be a meta coupled pair that revealed free hydroxyl groups at the C-5 and C-7 
positions. While the protons in ring B were observed at δH 6.31 [(H-3', d) 2.4 Hz], 6.28 [(H-5', 
dd) 2.0 Hz, 8.4 Hz], and 6.97 [(H-6', d) 8.4 Hz]. A deshielded singlet that is characteristic of all 
isoflavones, signifying the olefinic proton in ring C, was observed at δH 7.93 (H-2, s).  
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Figure 4.11:
1
H NMR spectrum of compound C3 in CD3OD. 
 
The 
13
C NMR spectrum (Figure 4.12; Table 4.1) showed twelve aromatic carbons δc 163.6 (C-5), 
100.2 (C-6), 162.2 (C-7), 94.8 (C-8), 159.7 (C-9), 106.1 (C-10), 110.8 (C-1'), 160.2 (C-2'), 114.8 
(C-3'), 157.7 (C-4'), 108.1 (C-5') and 133.1 (C-6') of ring A and B. An olefinic carbon residing at 
δc 156.6 (C-2), quaternary carbon at δc 122.5 (C-3) and carbonyl carbon at δc 182.5 (C-4, C=O) 
were observed and attributed to ring C.  
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Figure 4.12:
13
C NMR spectrum of compound C3 inCD3OD. 
 
 
Moreover, DEPT-135 spectrum (Figure 4.13) aided in assigning protonated carbons and 
proton/carbon correlations. From the spectral data of C3 and through to careful literature review, 
the compound was thus identified as 2'-hydroxygenistein (Figure 4.10). 
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Figure 4.13: DEPT-135 NMR spectrum of compound C3 in CD3OD. 
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4.2 STRUCTURE ELUCIDATION OF THE ISOLATED FLAVAN-3-OLS 
 
Structure elucidation of catechin (C4): 
 
 
Catechin (C4) 
Figure 4.14: Chemical structure of catechin (C4). 
 
Compound XIV4 (5.9 mg; 0.0045 %) was obtained as a dark yellow amorphous powder, and it 
was identified by comparing the obtained spectral data with the previously reported data (Hye et 
al., 2009). The 
1
H-NMR spectrum (Figure 4.15; Table 4.1) showed peaks at δH 4.51 [H-2, d, J(H-
2α, H-3α) 6.1 Hz]; 3.91 (H-3, m); 2.79 [H-4α, dd, J(H-4α, H-3α) 8 Hz, J(H-4α, H-4β) 16 Hz]; 
2.44 [H-4β, dd, J(H-4β, H-3α) 5.6 Hz, J(H-4β, H-4α) 16 Hz]; 5.78 [H-6, d, J(H-6, H-8) 2.4 Hz]; 
5.84 [H-8, d, J(H-8, H-6) 2.4 Hz]; 6.75 [H-2', d, J(H-2', H-6') 1.8 Hz]; 6.69 [H-5', d, J(H-5', H-6') 
8 Hz] and 6.64 [H-6', dd, J(H-6', H-2') 1.8 Hz, J(H-6', H-5') 8 Hz]. A strong coupling constant 
(J) between δH 4.51 (H-2α) and 3.91 (H-3α) of 6.1 Hz was observed, supporting a trans-
configuration between these two protons (Foo, 1987). 
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Figure 4.15:
1
H NMR spectrum of compound C4 in CD3OD. 
 
The 
13
C NMR spectrum (Figure 4.16; Table 4.1) of C4 showed carbon signals at δC 27.1 (C-4), 
67.4 (C-3), 81.5 (C-2), 94.1 (C-6), 94.9 (C-8), 99.4 (C-10), 113.9 (C-2'), 114.7 (C-5'), 118.6 (C-
6'), 130.8 (C-1'), 144.8 (C-3'), 144.9 (C-4'), 155.5 (C-5), 156.2 (C-9) and 156.4 (C-7). The above 
data showed that C4 consists of a flavan-3-ol backbone, through a thorough literature review; it 
was identified as catechin, a common procyanidin monomer typically isolated from green tea 
(Jeong and Kong, 2004). 
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Figure 4.16:
13
C NMR spectrum of compound C4 in CD3OD. 
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Structure elucidation of gallocatechin (C5): 
 
 
Gallocatechin (C5) 
Figure 4.17: Chemical structure of gallocatechin(C5). 
 
Conversely, compound XIV6 (287.4 mg; 0.22 %) was obtained as a brownish-red powder, and it 
demonstrated very similar NMR spectra to that of C4, with only slight differences. The 
1
H-NMR 
spectrum (Figure 4.18; Table 4.1) showed proton signals at δH 4.48 [H-2, d, J(H-2α, H-3β) 7.2 
Hz]; 3.93 (H-3, m); 2.46 [H-4α, dd, J(H-4α, H-3α) 7.8 Hz, J(H-4α, H-4β) 16.2 Hz]; 2.75 [H-4β, 
dd, J(H-4β, H-3α) 5.2 Hz, J(H-4β, H-4β) 16.2 Hz]; 5.86 [H-6, d, J(H-6, H-8) 2.0 Hz]; 5.84 [H-8, 
d, J(H-8, H-6) 2.0 Hz] and  6.33 (H-2' and H-6', s). The intense signal at δH 6.33 signifies the 
presence of two equivalent aromatic protons at the C-2' and C-6' positions in ring B. This peak 
was found to be absent in the case of C4. Likewise as in the case of C4, a strong coupling 
constant of 7.2 Hz was observed between δH 4.48 (H-2α) and 3.93 (H-3α), signifying a trans-
configuration between the two protons. In the case of both C4 and C5 epimers, the coupling 
constant between these signals would be very weak (Foo, 1987).  
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Figure 4.18:
1
H NMR spectrum of compound C5 in CD3OD. 
 
The 
13
C NMR spectrum (Figure 4.19; Table 4.1) revealed carbon signals at δC 26.6 (C-4), 67.3 
(C-3), 81.4 (C-2), 94.2 (C-6), 95.0 (C-8), 99.4 (C-10), 105.9 (C-2' and C-6'), 130.2 (C-1'), 132.6 
(C-4'), 145.4 (C-3' and C-5'), 155.4 (C-5), 156.2 (C-9) and 156.3 (C-7). The high intensity 
signals at δC 105.9 and 145.4, reveals the presence of two pairs of equivalent carbons i.e., C-2' 
with C-6', and C-3' with C-5', respectively. Another distinction for the spectra of C5, was a 
carbon signal residing at δC 132.6 signifying that C-4' was highly shielded in comparison to the 
C4 spectra, where the C-4' signal was found at δC 144.9. This is likely due to the additional 
electron density provided by the hydroxyl group at the C-5' position. 
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Figure 4.19:
13
C NMR spectrum of compound C5 in CD3OD. 
 
Moreover, the unusual dark brown colour of this pure compound (C5) is thought to be due to the 
presence of pyrogallol moiety (ring B) (Kumada and Kato, 1970). Such compounds are typically 
a white solid, but its samples and derivative samples (e.g., C5) are typically brownish because of 
its sensitivity toward oxygen (Fiege et al., 2014). The chemical structure of C5 was finally 
confirmed by comparison with the previously reported data (Medimagh et al., 2010) and 
identified as gallocatechin (Figure 4.17).  
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Table 4.1:
1
H [400 MHz: m, J(Hz)] and 
13
C (100 MHz) NMR spectral data of isolated 
compounds (C1 - C5) in CD3OD 
  
 
Code & 
No. IX3 (C1) IX5 (C2) X1 (C3) XIV4 (C4) XIV6 (C5) 
Chemical 
structure    
 
    
  13C 1H, m, J 13C 1H, m, J 13C 1H, m, J  
13
C 1H, m, J 13C 1H, m, J 
2 152.9 7.86, s 155.6 7.91, s 156.6 7.93, s 81.5 4.51, d, 6.1 81.4 4.48, d, 7.2 
3 123.0  121.4  122.5  67.4 3.91, m 67.3 3.93, m 
4 180.3  181.4  182.5  27.1 
H-4α: 2.44, dd, 
8.0, 16.0 
26.6 
H-4α: 2.46, dd, 
7.8, 16.2 
H-4β: 2.79, dd, 
5.6, 16.0 
H-4β: 2.75, dd, 
5.2, 16.2 
5 162.2  162.1  163.6  155.5  155.4  
6 100.2 6.02, d, 2.0 97.9 6.26, d, 2..2 100.2 6.14, d,  2.0 94.1 5.77, d, 2.4 94.2 5.80, d, 2.0 
7 169.1  165.9  166.2  156.4  156.3  
8 94.8 6.12, d, 2.0 91.8 6.46, d, 2.2 94.8 6.27, d, 2.0 94.9 5.84, d, 2.4 95.0 5.86, d, 2.0 
9 157.3  158.3  159.7  156.2  156.2  
10 103.6  105.6  106.1  99.4  99.4  
1' 122.3  109.2  110.8  130.8  130.2  
2' 130.0 7.23, d, 8.8 156.4  157.7  113.9 6.75, d, 1.8 105.9 6.33, s 
3' 114.8 6.72, d, 8.8 102.8 6.30, d, 2.4 104.2 6.31, d, 2.4 144.8  145.4  
4' 158.6  158.9  160.2  144.9  132.6  
5' 114.8 6.74, d, 8.8 106.5 
6.28, dd, 2.4, 
8.4 108.1 
6.28, dd, 2.4, 
8.4 114.7 6.69, d, 8.0 145.4  
6' 130.0 7.25, d, 8.8 131.8 6.96, d, 8.4 133.1 6.97, d, 8.4 118.6 
6.64,  dd, 1.8, 
8.0 105.9 6.33, s 
OMe    55.1 3.81, s          
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4.3 ANTI-TYROSINASE ACTIVITIES OF THE ISOLATED COMPOUNDS 
 
Tyrosinase inhibitors play an important role in healing and preventing pigmentation disorders in 
relation to hyperpigmentation, as they inhibit the overproduction of the tyrosinase enzyme, 
consequently leading to the adequate regulation of the production of melanin by the melanocytes. 
The effect of browning of food, due to the tyrosinase enzymatic effects has already been 
discussed, as within the broader aspects of the present study. Thus, the tyrosinase inhibitors are 
also required to inhibit and prevent the adverse effects of browning during food storage, 
processing and consumption, so as to maintain the commercial value or quality of such products. 
It has been shown that the free 1,3-dihydroxy system (ring A) in the isoflavone structure strongly 
affects both the inhibitory strength and the inhibitory mode of the isoflavones to mushroom 
tyrosinase (Chang, 2014). Therefore, the present study warrants the study of the anti-tyrosinase 
activity, as all the isolated compounds in this study consisted of a free 1,3-dihydroxy system and 
were all indeed found to be active against the tyrosinase enzyme. The IC50 values ranged 
between 31.5 and 69.5 µM (Figure 4.20; Table 4.2), showing the anti-tyrosinase effectiveness of 
the isolated compounds to be in the following order; C1 >C4 >C2 >C5 > C3.  
 
It was extrapolated that substitution of hydroxy group by a methoxy group has a significant 
effect on the tyrosinase activity as shown by cajanin (C2), which is an O-methylated derivative 
of 2'-hydroxygenistein (C3), as it revealed a higher activity than its hydroxylated analogue. 
Therefore, our study correlates the existing data, which has proven that methoxylation play a 
vital role in inhibition strength of the certain methoxylated compound to the mushroom 
tyrosinase activity (Kim et al., 2002). The tyrosinase inhibitory assay was performed as 
described in Section 3.1.6. Tyrosinase inhibitory effects of the isolated constituents from R. 
villosa are shown in Table 4.2 and portrayed in Figure 4.20. 
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Table 4.2: Tyrosinase inhibition of R. villosa constituents 
 
Compound 
code & No. 
Name of the isolated 
compound 
Average percentages of tyrosinase inhibition (%) in various concentrations 
(μg/mL) and anti-tyrosinase IC50 values (μg/mL &µM) of the isolated 
compounds 
100.0 
μg/mL 
50.0 
μg/mL 
25.0 
μg/mL 
12.5 
μg/mL 
6.25 
μg/mL 
IC50 
(μg/mL)  
IC50 
(µM) 
IX3 (C1)                                               Genistein 69.47 62.56 59.40 42.99 36.52 8.5 31.45 
IX5 (C2) Cajanin 66.27 59.46 50.31 42.12 36.95 11.7 38.97 
X1 (C3)                                                2'-hydroxygenistein 64.38 47.80 42.62 32.09 19.67 19.9 69.49 
XIV4 (C4) Catechin 75.83 68.10 51.81 41.24 28.77 10.7 36.86 
XIV6 (C5) Gallocatechin                                                 72.46 52.30 37.52 21.03 19.09 18.5 60.40 
Ko Kojic acid 98.48 97.74 94.15 89.32 87.02 0.9 6.33 
*Ko: Kojic acid was used as a positive control 
Figure 4.20: Effects of R. villosa constituents on inhibition of tyrosinase activity. 
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4.4 DISCUSSION ON THE ANTI-TYROSINASE ACTIVITIES OF THE ISOLATED 
COMPOUNDS 
The tyrosinase enzyme assay and its qualitative method (TLC bioautography), were used for the 
bioactivity-directed fractionation and isolation of the five active constituents in the present study. 
Through TLC bioautography (Figure 3.7) it was observed that main fractions IX – XV were the 
most active main fractions as they depicted clear white zones of tyrosinase inhibition. The 
isolated constituents were also bio-evaluated against the tyrosinase enzyme, where compound C1 
showed the highest tyrosinase inhibitory activity out of the isolated compounds. Generally, all 
the isolated compounds showed high activity against the mushroom tyrosinase, with IC50 value 
differences fluctuating from 4 – 8.5 fold less than that of kojic acid (positive control). 
Furthermore, the Fabaceae species are widely used in pharmaceutical and/or cosmetics, one of 
such species, which consists of the beneficial effects on skin, through its anti-tyrosinase, 
antioxidant and anti-inflammatory activities is that of Glycine max, well-known as soybean. It 
has been found that the effects of soybean are due to existence of isoflavones within it (Shamani, 
2008). From the results of the present study, a similarity is distinguished between the soybean 
and R. villosa, since R. villosa also showed a large number of its constituents to be isoflavones; 
hence this supports its use as a traditional cosmeceutical.  
Genistein (C1) (Perkin and Newbury, 1899) is said to be one of the most common isoflovones 
found in skin care products that are made from soybeans. Such skin care products brighten the 
skin, decrease redness, boost collagen production and improve skin tone (Jaliman, 2011). Unlike 
many synthetic substances that are applied on the skin, topically applied soybean does not exert 
any hormonal effects (Schmid et al., 2008).  Our findings confirm the existing data, which 
demonstrated that genistein (C1) is a natural tyrosinase inhibitor, as it was found to inhibit 
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mushroom tyrosinase activity with an IC50 value of 31.5 µM, only 4-fold less than that of kojic 
acid, an accepted standard tyrosinase inhibitor (6.3 µM).  
Scientific findings attest to the fact that isoflavones consists of estrogenic hormonal activity, 
since they have a similar structure with that of the human female hormone 17-β-estradiol. They 
can bind to both α and β estrogen receptors and they can imitate the action of the endogenous 
estrogens on target organs, thereby exerting many health benefits when used in some hormone-
dependent diseases (Vitale et al., 2013). Hence, post-menopausal women, whose estrogen 
production has dropped dramatically, may see obvious results when using soybean-containing 
moisturizing lotions, since the soybean natural phytoestrogens work to repair the thinness of the 
skin and the decreased collagen production caused by the lack of estrogen (Schmid et al., 2001). 
This confirms the use of soybean and R. villosa as a form of natural relief of estrogenic 
symptoms and/or other hormone-dependent diseases. Also, the effectiveness of soybean 
isoflavones in healing dermatological and hormone-dependant disorders validates the fact that 
the two plant species (Glycine max and R. villosa) can be used interchangeably, as they have 
similar biological and pharmacological activities. 
Genistein (C1) consists of derivatives such as the well-known ortho-hydroxygenisteins (OHGs) 
(Chang, 2014; Chang, 2009). These derivatives are typically isolated from fermented soybean 
foods, microbial fermentation broth feeding with soybean meal or produced by genetically 
modified microorganisms and they are rarely found in plant species (Chang, 2014). The ortho-
hydroxylated derivatives of genistein (C1) differ in structure-activity relationships, thus, the 
number and positions of hydroxyl groups in the chemical structures of such isoflavones intensely 
affect their function (Scotti et al., 2012). For instance, in the current experiment, 2'-
hydroxygenistein (C3) (Ingham, 1977), which is one of the OHGs, showed a lower activity when 
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compared to other isolated constituents, with an IC50 value of 69.5 µM, although it comprises of 
a free 1,3-dihydroxy system (ring A), together with a resorcinol moiety (ring B). Its analogue, 3'-
hydroxygenistein, however, has been reported to consist of an anti-tyrosinase IC50 value of 15.9 
µM, merely 1.5 fold less than that of the control, kojic acid (Ding et al., 2015). 
Cajanin (C2) (Bilyard et al., 1984) is the major constituent of Cajanus cajan, a species from 
Cajanus genus; Cajanus is one of the Cajaninae genera and it is very closely related to 
Rhynchosia and other two genera from this subtribe, Atylosia and Dunbaria (Pundir and Singh, 
1985; Pundir and Singh, 1986). The species Cajanus cajan has been found to have potent 
antioxidant, antiplasmodial, anti-inflammatory and hypocholesterolemic activities (Rerk-am et 
al., 2013, Pal et al., 2011). Rerk-am et al. (2013) revealed that although C. cajan seeds had a 
slight anti-tyrosinase activity with EC50 value of 267 µg/mL against the mushroom tyrosinase, it 
quenched DPPH radicals with EC50 value of 44.36 µg/mL, while it demonstrated substantial 
activity against the inhibition of the Fe
2+
-induced microsomal lipid peroxidation with EC50 of 
25.97 µg/mL. The latter data substantiates the high potential of C. cajan constituents and it also 
proves that such constituents can be beneficial in healing hyperpigmentation related disorders, 
particularly acne vulgaris due to the plant species‟ high inhibition of the Fe2+-induced 
microsomal lipid peroxidation (Bowe and Logan, 2010). The current study validated this 
postulation as the cajanin (C2) isolated from R. villosa was revealed to inhibit the mushroom 
tyrosinase with a substantial IC50 value of 39.0 µM. 
On the other hand, the present study totally disagrees with that of Meyer (1960), which revealed 
that catechin (C4) (Roux and Maihs, 1958) has a tanning property with respect to the human 
skin, and suggested that it may be a useful active ingredient for the treatment of 
hypopigmentation, leukoderma. Our study revealed catechin (C4) to have a high anti-
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melonogenesis effect with an IC50 value of 36.9 µM against the mushroom tyrosinase, proving 
that it may perform adequately as a depigmenting agent. Our results are substantiated by that of 
Sato and Toriyama (2009), as they found that catechin (C4) inhibited melanin synthesis in B16 
melanoma cells. Furthermore, Western blotting analysis was performed in their study which 
further indicated characteristics of the catechin (C4) inhibition of tyrosinase. 
The current study is consistent with the previous data (Ko et al., 2011), as they found out that 
gallocatechin (C5) (Saayman and Roux, 1965) has a tyrosinase inhibition percentage of 66.8 %, 
when screened at 100 µg/mL, and 55.7 % at 50 µg/mL. Therefore, in our study gallocatechin 
(C5) had a comparable tyrosinase inhibition percentage of 72.5 % when screened at 100 µg/mL, 
and 52.3 % at 50 µg/mL. Its epimer, epigallocatechin was reported to consist of an anti-
tyrosinase IC50 value of 0.7 mM by Ondonbayar et al. (2016), 11-fold less active when compared 
to that of gallocatechin (C5), which was found to be 60.4 µM in the current study. It can be 
postulated that the difference between catechin (C4; 36.9 µM) and gallocatechin (C5; 60.4 µM) 
anti-tyrosinase activities of nearly 23.5 µM (0.55-fold) is due to the presence of pyrogallol 
moiety (ring B) in gallocatechin (C5).  
Generally, the above-mentioned types of flavonoids are frequently referred to as green tea 
polyphenols (GTPs) due to their abundance in green tea made from Camellia sinensis leaves 
(Rahmani et al., 2015). Research has revealed that the modes of action of GTPs for the photo 
protection of the skin include ROS scavenging and regulation of genes to inhibit apoptosis, 
reduce inflammation, improve the skin barrier, and to repair DNA (Hsu, 2005). Our results are 
consistent with previous documented data, since both compound C4 and C5 were found to be 
active against the mushroom tyrosinase enzyme. Additionally, all the isolated compounds were 
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active against mushroom tyrosinase. Hence this supports the traditional uses of R. villosa for skin 
depigmentation. 
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5.1 CONCLUSION 
 
Preliminary screening of the ten investigated plant species, viz. Cassine peragua, Cassipourea 
gummiflua, Clivia miniata, Cryptocarya myrtifolia, Gunnera perpensa, Kigelia africana, 
Protorhus longifolia, Rapanea melanophloeos, Rhynchosia villosa, and Senecio serratuloides 
against the tyrosinase enzyme showed that R. villosa was the most active plant species, as its root 
extract inhibited mushroom tyrosinase activity with 15.67 μg/mL. Therefore, further 
chromatographic studies were carried out on the plant extract leading to the isolation of 5 known 
flavonoids, namely, genistein (C1), cajanin (C2), 2′-hydoxygenistein (C3), catechin (C4), and 
gallocatechin (C5). Furthermore, the tyrosinase inhibitory activity of the isolated compounds 
was also tested, and the purified constituents showed the highest activity for C1 (31.45 µM), 
followed by C4 (36.86 µM), C2 (38.97 µM), C5 (60.40 µM), and C3 (69.49 µM). 
Although there are a large number of Rhynchosia species occurring in S. Africa, research 
available for their biological and pharmacological importance is insufficient. For instance, there 
is no documented scientific or ethnomedicinal information that justifies the traditional uses of R. 
villosa. Therefore, to the best of our knowledge and according to the Sci-Finder database, the 
current investigation is the first scientific report to be carried out on R. villosa. In the present 
study, tyrosinase inhibitory activity demonstrated by R. villosa and examination of its 
constituents and their possible biological application in cosmetic products as skin lighteners was 
carried out. 
To extrapolate, our research work has substantiated the projected hypotheses of the R. villosa 
potential in healing dermatological anomalies. According to our findings, it is possible that the R. 
CHAPTER FIVE 
CONCLUSION AND RECOMMENDATIONS 
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villosa root can bring about a transformation in the manufacturing of skin-care products by the 
personal care industry. Thus, its tyrosinase inhibitory effects makes it a candidate tyrosinase 
inhibitor that can be used as depigmenting agent for the treatment or prevention of pigmentation 
disorders in relation to hyperpigmentation. Moreover, obtained results justify the traditional use 
of R. villosa for skin depigmentation. 
5.2 RECOMMENDATTIONS 
 
From the above, it is suggested that: 
 A reasonable amount of raw material of the examined plant species must be used in 
future, so to be able to obtain the available constituents in the plant of interest in 
adequate amounts; which in return will allow further relative biological studies on 
such isolated constituents. 
 Appropriate action must be taken to guarantee that potential active constituents are 
not lost or destroyed during extraction of the plant to be examined. If the plant was 
chosen on the basis of traditional uses then it is needed to prepare the extract exactly 
as described by traditional healer in order to simulate as closely as possible the 
traditional herbal remedy. 
 Since melanogenesis is a series of biological reactions which proceeds through a free 
radical mechanism, it could be disrupted by selective use of antioxidants. Hence to 
test the isolated constituents‟ antioxidant potential would do justice in confirming 
their uses in manufacturing of cosmetics.  
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 Also, since the isolated compounds are active on the biological activity of interest, a 
rapid search to verify their structural integrity and binding effect to targets of the 
tyrosinase activity via a commonly used in silico or technique of structure-based 
virtual screening known as „docking‟ may be beneficial. 
 Furthermore, uses of these isolated constituents in beauty care products and 
pharmaceutical industry will require confirmation of their capability to reduce 
undesirable skin enzymatic effects in in vivo models. Additional investigation, for 
instance, cytotoxicity determination, reduction of cellular melanin formation and anti-
tyrosinase activities in B16F10 melanocytes and dermatological related clinical tests 
are suggested with a specific end goal to transform the present discoveries into 
conclusive cosmeceuticals as well as pharmaceutical product formulations. 
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